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Heterocyclic compounds are organic compounds that contain a ring 
structure containing atoms in addition to carbon, such as sulfur, oxygen or 
nitrogen, as part of the ring. They may be either simple aromatic rings or non-
aromatic rings.      
These heterocyclic compounds constitute the largest and most varied 
family of organic compounds.  Many of these compounds are of biological 
importance, such as nucleic acids and certain vitamins, hormones, and 
pigments.  Further, these heterocyclic compounds are widely distributed in 
nature, which is essential to life. For example, DNA, Hemoglobin, 
Chlorophylls, vitamins etc. contains various types of heterocycles. Thus, 
heterocycles dominates the field of biochemistry and medicinal chemistry. 
Some of heterocyclic compounds are also used as chemical intermediates 
and solvents in the pharmaceutical, chemical, textile, dye-stuffs, petroleum, 
photography industries, agrochemicals and are of increasing importance in 
many others include polymers, adhesive, molecular engineering etc. 
Thus, in the present work, some heterocyclic compounds have been 
synthesized and their physicochemical and biological properties were studied. 
The present work is divided into following chapters: 
 
? Chapter - 1:       General Introduction 
? Chapter - 2:       Synthesis and characterization  
? Part-1: Synthesis of tetrahydropyrimidine derivatives. 
 Section-1: tetrahydropyrimidines. 
 Section-2: tetrahydropyrimidopyrimidines  
? Part-2: Synthesis of tetrahydroquinoline derivatives. 
 Section-1: tetrahydroquinolines  
 Section-2: pyrimidotetrahydroquinoline  
? Part-3: Synthesis of benzimidazole derivatives. 
Section-1: Condensation of benzimidazoles with acetyl coumarine  
 
? Chapter - 3:       Physico chemical Properties 
Section-I        Acoustical Properties 
Section-II     Density and Refractive Index 
Section-III    Conductance 
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Section-IV      Solubility Studies 
Section-V     Thermal Analysis 
Section-VI      Dissociation Constants 
Section-VІІ Partition coefficient. 
? Chapter - 4:        Biological activities 
 
CHAPTER - 1 
GENERAL INTRODUCTION 
 This chapter describes literature survey of synthesis, characterization, 
applications, physicochemical studies and antibacterial activities of all the 
synthesized compounds. 
 
CHAPTER-2 
SYNTHESIS AND CHARACTERIZATION 
This chapter deals with synthesis and characterization of different 
bioactive heterocyclic compounds. 
 
? Part-1: Studies of some tetrahydropyrimidine derivatives. 
Section-1: tetrahydropyrimidine  
 
    
NH
N NH2SH
N
 
 
 
Section-2: tetrahydropyrimidopyrimidines. 
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? Part-2: Studies of some tetrahydroquinoline derivatives. 
 Section-1: Tetrahydroquinolines. 
           
N
N
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 Section-2: Pyrimidotetrahydroquinoline 
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? Part-3: Studies of some benzimidazole derivatives. 
Section-1: Condensation of benzimidazoles with acetyl coumarine 
derivative. 
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The characterization of all the synthesized compounds was done by IR, 
NMR and mass spectral data. 
 
CHAPTER-3: PHYSICO CHEMICAL PROPERTIES 
 
 Some physico chemical properties of some compounds have also been 
studied. This chapter is further subdivided into eight sections. 
 
 Section-I:  Acoustical Properties 
 
 In this chapter, density, sound velocity and viscosity of above 
synthesized tetrahydropyrimidines were measured in dimethylformamide and 
chloroform solutions of various concentrations at 303.15 K. From these 
experimental data, various acoustical parameters such as isentropic 
compressibility, Rao’s molar sound function, specific acoustical impedance, 
internal pressure, Vander Waals constant, free volume, solution number etc. 
were evaluated and the results are discussed in terms of molecular 
interactions occurring in these solutions. 
 
 Section-II:  Density and Refractive Index 
 
Refractive index is a property of the material and is extremely useful in 
chemical analysis. In this chapter, the refractive index and density was 
measured in dimethylformamide and chloroform solutions at 303.15 K. From 
the refractive index measurements of solutions, the density and refractive 
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index of synthesized compounds were determined. The molar refraction of 
these compounds has also been evaluated from the density and refractive 
index values. 
 
 Section-III:  Conductance 
 
This chapter deals with the conductance measurement of solutions of 
tetrahydropyrimidine derivatives in dimethylformamide and chloroform 
solutions of different concentrations at 303.15 K. From these experimental 
values, specific conductance and equivalent conductance were evaluated. 
 
 Section-IV:  Solubility 
 
The molar heat of solution of a substance can be determined from the 
solubility measurement at different temperatures. In the present chapter,   
heat   of   solution   for all the synthesized tetrahydropyrimidines were 
determined at different temperatures (293.15 -313.15 K) in methanol, ethanol 
and chloroform. From these experimental data various thermodynamic 
parameters were evaluated. 
 
   
Section-V:  Thermal Properties 
 
 This chapter describes the thermal properties of tetrahydropyrimidines. 
The Thermo Gravimetric Analysis (TGA) measurements and Differential 
Scanning Calorimeter (DSC) analysis were made. From these measurements, 
various kinetic parameters were evaluated. Further, thermal stability of 
various compounds were also determined. 
 
 Section-VI:  Dissociation Constants 
 
In this Chapter, the dissociation constant of some 
tetrahydropyrimidines were studied in methanol by using UV-Visible 
spectroscopy. 
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Section-VІІ: Partition coefficient. 
  
 Partition coefficient of ten tetrahydropyrimidine derivatives was 
determined by using UV-Visible spectroscopy. 
CHAPTER–4: BIOLOGICAL ACTIVITIES 
 
 This chapter deals with antibacterial activity of all the synthesized 
compounds against different microbes.  
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    GENERAL INTRODUCTION 
 Heterocyclic compounds constitute the largest, most varied family of organic 
compounds and are very widely distributed in nature. They play a vital role in the 
metabolism of all the living cells. The study of heterocycles is of great interest both 
from the theoretical as well as practical stand point. A heterocyclic compound is one 
which possesses acyclic structure at least two different kinds of atoms in the ring. 
The most common types contain largely carbon atom, nitrogen, oxygen and sulphur 
but many other elements, including even bromine, chlorine can also be present. The 
heterocyclic containing the less common atoms have been subject to much 
investigation in recent years. 
 Heterocyclic chemistry and medicinal chemistry share a venerable common 
history. Many of the founders of heterocyclic systems had an intense interest not 
only in molecules from nature but also in the effects of synthetic compounds on 
living systems. The current interest in the creation of large, searchable libraries of 
organic compounds has captured the imagination of organic chemists and the drug 
discovery community. In numerous laboratories, the efforts are focused on the 
introduction of chemical diversity, which have been recently reviewed and 
pharmacologically interesting compounds have been identified from libraries of 
widely different compositions. 
 Today, the chief sources of agents for the cure, the improvement or the 
prevention of diseases are the heterocyclic compounds, natural or synthetic. Such 
agents have their origin in a number of ways (a) from naturally occurring materials - 
of both plant and animal origin, and (b) from the isolation of organic compounds 
synthesized in laboratory whose structures are closely related to those of naturally 
occurring compounds 
Most of the alkaloids, pigments (such as indigo, haemoglobin, anthocyanin 
etc.), some well known drugs (like penicillin, streptomycin, sulphathiazole, 
pyrenthrin, rotenmone, strychnine, reserpine, etc.) consist of heterocyclic ring 
system. Heterocyclic compounds have great applicability in pharmaceutics because 
 Pa
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they have specific chemical reactivity and provide false synthons in biosynthetic 
process or block the normal functioning of biological receptors.  
Taking in view of the applicability of heterocyclic compounds, the present 
work was undertaken to synthesize some new heterocycles such as tetrahydro 
pyrimidine, tetrahydro quinoline, benzimidazole etc. Green chemistry aspect is used 
for the synthesis of some heterocyclic compounds.  
 
AIMS AND OBJECTIVES: 
? To synthesize several derivatives baring pyrimidine, quinoline, benzimidazole, 
 coumarine nucleus. 
? To characterize these synthesized compounds for structure elucidation by IR, 
 1H NMR and Mass spectral studies. 
? To study the physico chemical properties such as acoustical properties, 
 density, refractive index, conductance, solubility, partition coefficient, thermal 
 properties and dissociation constants of some compounds, in different 
 solvents. 
? To evaluate antibacterial activity of some of these synthesized compounds 
 against different bacterial strains. 
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GENERAL REMARKS: 
1. Melting points were recorded by open capillary method and are uncorrected. 
2. Infrared spectra were recorded on SHIMADZU FTIR-8400 (Diffuse reflectance 
 attachment) in the frequency range of 4000-400 cm-1 using KBr. Spectra were 
 calibrated against the polystyrene absorption at 1610 cm-1. 
3. 1H NMR spectra were recorded on BRUKER AVANCE II 400 spectrometer.   
 Making a solution of samples in DMSO d6 solvent using tetramethylsilane 
 (TMS) as the internal standard unless otherwise mentioned, and are given in 
 the δ scale. 
4. Mass spectra were recorded on SHIMADZU GCMS-QP2010 spectrometer   
 operating at 70 eV using direct injection probe technique. 
5.  Analytical thin layer chromatography (TLC) was performed on Merck precoated 
 silica gel-G F254 aluminium plates. Visualization of the spots on TLC plates was 
 achieved either by exposure to iodine vapor or UV light. 
6. The chemicals used for the synthesis of products were purchased from 
 Spectrochem, Sisco Research Laboratories (SRL), Thomas- Baker, SD fine 
 chemicals and Loba chemie. 
7. The structures and names of all the compounds given in the experimental 
 section were generated using ACD Chemsketch version 11.0 
 Pa
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         INTRODUCTION 
 The intense activity in the field of pyrimidine chemistry during the past 
decade, from both academic and industrial laboratories, has prompted our 
interest in the Biginelli reaction. Pyrimidine is the trivial name for 1, 3-diazine 
where two meta CH units in benzene are replaced by nitrogen atom. The 
pyrimidine ring system undoubtedly belongs to the most important 
heterocycles in nature, as it represent the main structure of many biologically 
significant compounds, including nucleosides and nucleotides. 
 Tetrahydropyrimidine is higher saturated pyrimidine nucleus with two 
less double bonds. The tetrahydropyrimidines are small, highly soluble 
organic molecules, neutral at physiological pH, which do not interfere with 
normal cellular functions. They are zwitterion molecules, and the amidine 
group of the THPs is positively charged (1, 2). 
 Tetrahydropyrimidine has the great property of their synthetic 
compatibility. It can easily be modified (3). Only few general methods for the 
synthesis of tetrahydropyrimidine-2- thione derivatives have been reported. In 
1893, Biginelli (4) reported the synthesis of functionalized 3, 4-dihydro- 
pyrimidin-2(1H)-ones via three-component acid catalysed condensation 
reaction of an aromatic aldehyde, urea, and ethyl acetoacetate. In the past 
decade, this long neglected multicomponent reaction has experienced a 
remarkable revival, mainly due to the interesting pharmacological properties 
associated with this dihydropyrimidine (5). The main disadvantage of this 
synthesis is the low yields of the desired pyrimidines. A very attractive 
approach to the synthesis of Biginelli compounds has been developed by 
Atwal and co-workers (6-8). This approach is based on the reaction of arylidene 
of oxoesters with S-(4-methoxybenzyl)isothiourea or o-methylisourea in the 
presence of sodium bicarbonate followed by transformation of the obtained 
dihydropyrimidine derivatives into tetrahydropyrimidine derivative.  
 Many researchers have suggested various ways to synthesize various 
tetrahydropyrimidine derivatives in protic solvents or without solvent (9-16). 
These compounds can also be synthesized by benzene like aprotic solvents 
(17). Svetlik et al. have used the dialkyl acetone-1, 3-dicarboxylates as active 
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methylene compounds (18). Some environmentally benign processes can be 
employed to synthesize the tetrahydropyrimidines. Neat reactants subjected 
to microwave radiation gave the required products more quickly and in better 
yields in comparison to traditional methodologies (19-22). Under different 
reduction conditions, dihydropyrimidines are converted into 
tetrahydropyrimidine derivatives (23).  
 In recent years, tetrahydropyrimidine-2-thione derivatives received 
significant attention owing to their diverse range of biological properties (24). 
These derivatives are reported to possess calcium antagonist (25-28), anti-
inflammatory (29-31), analgesic (32), antitumor (33) antidepressant (34), 
antibacterial and antifungal effects (35-37). Tetrahydropyrimidines are found to 
be accumulating in a significant amount and induces thermo tolerance in E. 
coli (38). 
 Over the past few years, several novel tetrahydropyrimidine like 
amidine derivatives have been synthesized and tested for muscarinic agonist 
activity in rat brain (39-41). Several novel tetrahydropyrimidine derivatives 
exhibited muscarinic agonist activity in rat brain. Such compounds might be 
useful in treating Alzheimer’s disease (42). Chhillar et al. have synthesized 
three different tetrahydropyrimidine along with ten dihydropyridine derivatives 
and examined their activity against pathogenic strains of Aspergillus 
fumigatus and Candida albicans (43). 
 Thus, in sections 1 and 2, some new tetrahydroprimidines and tetra 
hydropyrimidopyrimidines have been synthesized and characterization of 
these synthesized compounds is done by IR, NMR and mass spectral data.  
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    SYNTHESIS AND CHARACTERIZATION 
Synthesis of 4-amino-6-aryl-2-sulfanyl-1,4,5,6-tetrahydropyrimidine-5-
carbonitrile: 
First of all, sodium ethoxide was prepared by adding pieces of sodium 
metal in ethanol. To this solution (100 ml), malano nitrile (0.01 mole) and 
desired aldehyde (0.01 mole) was added. When the solution becomes clear,  
0.76 gm of thiourea was mixed and the mixture was refluxed in a water bath 
for about 12 hours. The reaction mixture was then allowed to cool at room 
temperature and then poured into the crushed ice. The solution was 
neutralized with aqueous HCl solution and product was extracted in 
chloroform. Organic layer was washed with brine solution and anhydrous 
sodium sulphate was added to remove moisture from it. The product was 
recovered from chloroform solution by rota vapour under high vacuum 
condition.  Solid product obtained was recrystalised from fresh chloroform. 
 
Reaction Scheme: 
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 Following compounds were synthesized through above reaction 
scheme. 
MDT 1:  4-amino-6-(4-hydroxy-3-methoxyphenyl)-2-sulfanyl-1,4,5,6-
tetrahydro -pyrimidine-5-carbonitrile 
MDT 2:  4-amino-6-(4-methoxyphenyl)-2-sulfanyl-1,4,5,6-tetrahydropyrimi- 
dine-5-carbonitrile 
MDT 3:  4-amino-6-(4-hydroxyphenyl)-2-sulfanyl-1,4,5,6-tetrahydropyrimi-
dine-5-carbonitrile 
MDT 4:  4-amino-6-(4-chlorophenyl)-2-sulfanyl-1,4,5,6-tetrahydropyrimi- 
dine-5-carbonitrile 
MDT 5:  4-amino-6-(3-chlorophenyl)-2-sulfanyl-1,4,5,6-tetrahydropyrimi- 
dine-5-carbonitrile 
MDT 6:  4-amino-6-(4-fluorophenyl)-2-sulfanyl-1,4,5,6-tetrahydropyrimidine 
-5-carbonitrile 
MDT 7:  4-amino-6-(3-nitrophenyl)-2-sulfanyl-1,4,5,6-tetrahydropyrimidine-
5-carbonitrile 
MDT 8:  4-amino-6-phenyl-2-sulfanyl-1,4,5,6-tetrahydropyrimidine-5-carbo- 
nitrile 
MDT 9: 4-amino-6-(furan-2-yl)-2-sulfanyl-1,4,5,6-tetrahydropyrimidine-5-
carbonitrile 
MDT 10: 4-amino-6-[(Z)-2-phenylethenyl]-2-sulfanyl-1,4,5,6-tetrahydro- 
pyrimidine-5-carbonitrile 
 The various physical constants such as Rf value, melting point and 
percentage of yield for all the synthesized tetrahydropyrimidines are given in 
Table 1.1. 
 The characterization was done by IR, 1H NMR and mass spectra. 
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Table 1.1: Physical constants of compounds of MDT series. 
* Ethyl acetate : Hexane : 3 : 7 
Sr. No. Code R M.F. 
M. W. 
g 
Rf* 
Value 
M.P. 
oC 
Yield 
% 
1. MDT 1 4-OH, 3-OCH3-C6H4- C12H14N4O2S 278.3 0.36 140 75 
2. MDT 2 4-OCH3-C6H4- C12H14N4OS 262.3 0.41 118 82 
3. MDT 3 4-OH-C6H4- C11H12N4OS 248.3 0.38 190 78 
4. MDT 4 4-Cl-C6H4- C11H11ClN4S 266.8 0.45 168 69 
5. MDT 5 3-Cl-C6H4- C11H11ClN4S 266.8 0.42 157 67 
6. MDT 6 4-F-C6H4- C11H11FN4S 250.3 0.50 130 63 
7. MDT 7 3-NO2-C6H4- C11H11N5O2S 277.3 0.60 101 61 
8. MDT 8 C6H5- C11H12N4S 232.3 0.69 90 80 
9. MDT 9 4(α-C4H3O)- C9H10N4OS 222.3 0.32 81 83 
10. MDT 10 C6H4-CH=CH- C13H14N4S 258.3 0.72 164 58 
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Table 1.3: IR spectral data of other synthesized tetrahydropyrimidines. 
 
Compounds 
IR ν, (cm-1) 
C=C S-H N-H C≡N 
MDT 2 1515.15 2559.55 3438.28 2210.12 
MDT 3 1520.25 2555.46 3436.25 2209.36 
MDT 4 1518.57 2558.87 3439.14 2212.03 
MDT 5 1514.32 2558.36 3429.98 2223.05 
MDT 6 1516.62 2557.58 3431.25 2228..59 
MDT 7 1517.49 2555.18 3438.56 2214.41 
MDT 8 1514.48 2559.18 3425.26 2210.00 
MDT 9 1519.15 2556.19 3422.23 2236.48 
MDT 10 1518.18 2551.36 3421.59 2222..12 
  
F
c
igure 1.2: 1H 
arbonitrile (M
NMR spectra 
DT 1).  
of 4-amino-6-(4-hydroxy-3-
 
methoxyphenyl)-2-sulfanyl
  
-1,4,5,6-tetrah
NNH2
N
O
f
g
h
i
j     k
ydropyrimidin
NH
SH
O
CH3H
a
b
c
d
e      
e-5-
P
a
g
e
1
2
 
 
  
 
Pa
ge
13
 
Table 1.4: 1H NMR spectral data of 4-amino-6-(4-hydroxy-3-methoxy 
phenyl)-2-sulfanyl-1,4,5,6-tetrahydropyrimidine-5-carbonitrile (MDT 1). 
 
Signal 
No. 
Signal 
Position 
(δ ppm) 
Relative No.
of Protons 
Multiplicity Inference 
J 
(Hz) 
1 1.25 1 singlet -SH (a) - 
2 1.65 3 singlet 
-NH (b),  
-NH2 (k) 
- 
3 2.68-2.70 1 doublet -CHj- 7.5 
4 2.29-2.39 1 triplet -CHi- - 
5 3.98 3 singlet -OCH3 - 
6 4.42-4.46 1 doublet -CHc- 10.1 
7 6.43 1 singlet -OH - 
8 7.02-7.04 1 doublet Ar-Hd 2.33 
9 7.27-7.33 1 triplet Ar-Hh - 
10 7.70-7.72 1 doublet Ar-Hg 7.6 
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Scheme 1.1: Proposed mass fragmentation of 4-amino-6-(4-hydroxy-3-methoxyphenyl)-2-sulfanyl-1,4,5,6-tetrahydro 
pyrimidine-5-carbonitrile (MDT 1). 
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  SYNTHESIS AND CHARACTERIZATION 
 
Synthesis of 5-aryl-7-sulfanyl-5,6-dihydropyrimido[4,5-d]pyrimidin-4(1H)-
one: 
 
Synthesis of 4-amino-6-aryl-2-sulfanyl-1,4,5,6-tetrahydropyrimidine-5- 
carbonitrile- Discussed in Section 1. 
Synthesis of 5-aryl-7-sulfanyl-5,6-dihydropyrimido[4,5-d]pyrimidin-4 
(1H)-one- To the solution of recrystallized product (MDT series) obtained from 
section 1 (0.01 Mole) in formic acid (25 ml), 3-4 drops of sulphuric acid was 
added and the solution was refluxed in a water bath for 4 hours. Then, the 
reaction mixture was allowed to cool at room temperature and was neutralised 
with sodium bicarbonate carefully. From neutralized solution, product was 
extracted in the ethyl acetate. The organic layer was washed with brine 
solution and anhydrous sodium sulphate was added to remove moisture from 
it. The product was recovered from the solution with the help of rota vapour 
under high vacuum condition. The solid product obtained was recrystalised 
from methanol. 
Reaction Scheme: 
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 Following compounds were synthesized through above reaction 
scheme: 
MPP 1:  5-(4-hydroxy-3-methoxyphenyl)-7-sulfanyl-5,6-dihydropyrimido 
[4,5-d] pyrimidin-4(3H)-one 
MPP 2:  5-(4-methoxyphenyl)-7-sulfanyl-5,6-dihydropyrimido[4,5-d]pyrimi 
din-4 (3H)-one 
MPP 3:  5-(4-hydroxyphenyl)-7-sulfanyl-5,6-dihydropyrimido[4,5-d]pyrimi 
din-4 (3H)-one 
MPP 4:  5-(4-chlorophenyl)-7-sulfanyl-5,6-dihydropyrimido[4,5-d]pyrimidin-
4 (3H)-one 
MPP 5:  5-(3-chlorophenyl)-7-sulfanyl-5,6-dihydropyrimido[4,5-d]pyrimidin-
4 (3H)-one 
MPP 6:  5-(4-fluorophenyl)-7-sulfanyl-5,6-dihydropyrimido[4,5-d]pyrimidin-
4-(3H)-one 
MPP 7:  5-(3-nitrophenyl)-7-sulfanyl-5,6-dihydropyrimido[4,5-d]pyrimidin-
4(3H) -one 
MPP 8:  5-phenyl-7-sulfanyl-5,6-dihydropyrimido[4,5-d]pyrimidin-4(3H)-one 
MPP 9: 5-(furan-2-yl)-7-sulfanyl-5,6-dihydropyrimido[4,5-d]pyrimidin-
4(3H)-one 
MPP 10: 5-(2-phenylethenyl)-7-sulfanyl-5,6-dihydropyrimido[4,5-d]pyrimi 
din-4(3H)-one 
 
 The various physical constants such as Rf value, melting point and 
percentage of yield for all the synthesized compounds of MTP series are 
given in Table 2.1. 
 The characterization was done by IR, 1H NMR and mass spectra. 
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Table 2.1: Physical constants of compounds of MDT series. 
 *Ethyl acetate : Hexane : 5 : 5 
 
 
 
 
 
Sr. No. Code R M.F. M. W. g 
Rf* 
Value 
M.P. 
oC 
Yield 
% 
1. MPP 1 4-OH, 3-OCH3-C6H4- C13H12N4O3S 304.3 0.19 98 67 
2. MPP 2 4-OCH3-C6H4- C13H12N4O2S 288.3 0.22 96 72 
3. MPP 3 4-OH-C6H4- C12H10O2S 274.3 0.20 86 68 
4. MPP 4 4-Cl-C6H4- C12H9ClN4OS 292.7 0.32 84 55 
5. MPP 5 3-Cl-C6H4- C12H9ClN4OS 292.7 0.36 92 59 
6. MPP 6 4-F-C6H4- C12H9FN4OS 276.3 0.29 102 58 
7. MPP 7 3-NO2-C6H4- C12H9N5O3S 303.3 0.45 85 66 
8. MPP 8 C6H5- C12H10N4OS 258.3 0.39 105 60 
9. MPP 9 4(α-C4H3O)- C10H8N4O2S 248.3 0.17 65 69 
10. MPP 10 C6H4-CH=CH- C14H12N4OS 284.3 0.42 74 45 
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Table 2.3: IR spectral data of other synthesized pyrimidopyrimidines. 
 
Compounds 
IR ν, (cm-1) 
C=C str S-H str  N-H str 
C=O str 
(cyclo) 
MPP  2 1512.23 2571.59 3465.23 1630.23 
MPP  3 1514.56 2569.26 3465.12 1625.14 
MPP  4 1502.52 2574.13 3468.12 1622.78 
MPP  5 1509.55 2575.23 3465.23 1631.33 
MPP  6 1504.44 2571.46 3466.12 1629.82 
MPP  7 1505.05 2569.19 3452.58 1624.39 
MPP  8 1512.13 2573.38 3458.99 1631.31 
MPP  9 1512.28 2548.27 3461.69 1632.25 
MPP  10 1500.22 2565.22 3464.78 1635.52 
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Table 1.4: 1H NMR spectral data of 5-(4-hydroxy-3-methoxyphenyl)-7-
sulfanyl-5,6-dihydropyrimido[4,5-d]pyrimidin-4(3H)-one (MPP 1).  
  
Singal 
No. 
Signal 
Position 
(δ ppm) 
Relative No. 
of Protons 
Multiplicity Inference 
1 1.71 1 singlet -SH (a) 
2 2.27 1 singlet -NH (b) 
3 3.92 3 singlet -OCH3 (e) 
4 4.60 1 singlet -CHc- 
5 5.09 1 singlet -OH 
6 6.43-6.53 3 multiplet Ar-Hd,h,g 
7 7.66 1 singlet Ar-Hj 
8 7.99 1 singlet -NH- (I) 
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Scheme 2.1: Proposed mass fragmentation of 5-(4-hydroxy-3-methoxyphenyl)-7-sulfanyl-5,6-dihydropyrimido[4,5-
d]pyrimidin-4(3H)-one (MPP 1).  
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          INTRODUCTION 
 Quinoline is a well known molecule for chemists as its derivatives have 
been used as many drug molecules (e.g.; chloroquine, amidoquine, pamaquin, 
enrofloxacin, difloxacin, ofloxacin, etc.) or as precursor of many bioactive entities 
. Quinoline ring system is also found in alkaloid (e.g; cinchonan, chelidonine, 
etc.) like biological macromolecules.  
 Tetrahydroquinoline is also a useful molecule from pharmaceutical 
research point of view. Both 1,2,3,4-tetrahydroquinoline and 5,6,7,8-
tetrahydroquinoline show reaction convenience and various types of activity. 
Unsubstituted 5,6,7,8-tetrahydroquinoline is a clear to yellow coloured liquid of 
boiling point 2380 C.  
 Various researchers have indicated presence of many tetrahydroquinoline 
derivatives as transfer protein inhibitors (1), CRTH2 inhibitors (2), serine protease 
inhibitors (3), proton pump inhibitors (4), protein farnesyltransferase inhibitors (5, 6), 
allosteric inhibitors (7), etc. This moiety has also been reported as antagonists (8-
13) and agonists (14, 15) of different types of receptors. Further, tetrahydroquinoline 
derivatives possess various types of activities like antidepressant (16), antiulcer 
(17), diuretic and antihypertensive (18), spasmogenic activity (19), gastrc 
antisecretory (20), analgesic (21), schistosomicidal (22, 23), antitussive, anorectic, 
and psychostimulant (24), antihistamine (25), antimalarial (26), antimicrobial (27), 
antifungal (28) etc. Asolkar et al. have reported some tetrahydroquinoline as 
antibiotic (29). Some other tetrahydroquinoline have also been reported to 
possess anti-tubercular activity (30) and are useful in treatment of neurological 
and neurogenerative disorders (31). Straten et al. have patented the four step 
preparation of a tetrahyddroquinoline derivative which can be used to control 
fertility (32). These compounds are also known to be useful as cholesterol 
lowering agent (33). 
 Due to these all usefulness of tetrahydroquinoline, chemists are regularly 
attracted towards the synthesis (34, 35). Different types of catalysts have been 
used to yield different products (36-38). Many researchers have studied 
streochemical aspects of tetrahydroquinoline derivatives (39-43). Dhar et al. (44) 
have performed SAR study whereas Salam et al. (45) have performed docking 
study of tetrahydroquinoline derivatives. Zalukaev et al. have studied 
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intramolecular interactions of discussed compound (46). To synthesize this entity, 
green chemistry approaches like microwave irradiated reaction (47), solvent free 
catalytic reaction (48), multicomponent reaction (MCR) procedure etc. can also be 
employed.  
 Multicomponent reactions (MCRs) are of increasing importance in organic 
and medicinal chemistry (49-53). Recently when emphasis is put on speed, 
diversity, and efficiency in the drug discovery process (54), MCR strategies offer 
significant advantages over conventional linear-type syntheses (49-53). In such 
reactions, three or more reactants come together in a single reaction vessel to 
form new products that contain portions of all the components (49-53). So, in this 
section synthesis of tetrahydroquinolin were carried out by multicomponent 
reaction method.  
 These tetrahydroquinoline derivatives have also been used to synthesize 
pyrimidoquinolines (55-57).  These pyrimidoquinolines are important compounds 
because of their biological properties, which are known to depend mainly on the 
nature and position of substituent. Various biological properties such as 
antimalarial (58), anticancer (59), antimicrobial (60, 61), and anti-inflammatory 
activities (62, 63) etc. have been reported.  
 Our aim in the work presented herein was to synthesize pyrimido[4,5-
b]quinolines using tetrahydroqinolinecarbonitriles as building blocks (Section-1). 
In section 2, synthesis of pyrimidoquinoline is discussed by cyclization of 
tetrahydroquinoline. The characterization of all the synthesized compounds were 
also done by IR, NMR and mass spectra. 
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     SYNTHESIS AND CHARACTERIZATION 
 
Synthesis of 2-amino-4-aryl-5,6,7,8-tetrahydroquinoline-3carbonitrile: 
Synthesis of benzylidenepropanedinitrile: 
 A mixture of vanillin (as aromatic aldehydes) (0.01M), malanonitrile 
(0.01M) and potassium carbonate (in excess) was crushed throughly by mortar 
pastel method for half an hour. To this solid mass, water was added to remove 
excess of potassium carbonate. The solution was then neutralized with aqueous 
hydrochloric acid solution. The resulting crude product was filtered and 
crystallized from dichloromethane. 
Reaction Scheme: 
 
 
 
 
 
 
 
 
Synthesis of 2-amino-4aryl-5,6,7,8-tetrahydroquinoline-3-carbonitrile:  
 The above crystallized product (benzylidene propanedinitrile) was 
dissolved in N, N-dimethyl formamide. Equimolar amount of cyclohexanone was 
added to this solution with shaking. The resulting solution was then mixed with 
saturated solution of ammonium acetate in methanol and the mixture was 
refluxed at 1500C for 4 hours. The reaction was monitored by TLC in the solvent 
system of EA : Hexane : 2:8. After completion of reaction, excess DMF was 
removed by rota vapour at high vacuum condition.  The reaction mixture was 
then poured into ice and product was extracted in ethyl acetate. The organic 
layer was washed with brine solution and anhydrous sodium sulphate was added 
to remove moisture from it. The ethyl acetate was removed and solid product 
obtained was recrystalised from fresh ethanol. 
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Reaction Scheme: 
 
        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
O
NH4OAc
N
N
NH2
NC
CN
+
R
R
DMF
120 °C
 Pa
ge
37
 
 Following compounds were synthesized through above reaction scheme. 
MBH 1:  2-amino-4-(4-hydroxy-3-methoxyphenyl)-5,6,7,8-tetrahydro quino 
line-3-carbonitrile 
MBH 2:  2-amino-4-(4-methoxyphenyl)-5,6,7,8-tetrahydroquinoline-3-carbo 
nitrile 
MBH 3:  2-amino-4-(4-hydroxyphenyl)-5,6,7,8-tetrahydroquinoline-3-carbo 
nitrile 
MBH 4:  2-amino-4-(4-chlorophenyl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile 
MBH 5:  2-amino-4-(3-chlorophenyl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile 
MBH 6:  2-amino-4-(4-fluorophenyl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile 
MBH 7:  2-amino-4-(3-nitrophenyl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile 
MBH 8:  2-amino-4-phenyl-5,6,7,8-tetrahydroquinoline-3-carbonitrile 
MBH 9: 2-amino-4-(3,4-dimethoxyphenyl)-5,6,7,8-tetrahydroquinoline-3-
carbonitrile 
MBH 10: 2-amino-4-[4-(dimethylamino)phenyl]-5,6,7,8-tetrahydro quinoline-3-
carbonitrile 
  
 The various physical constants such as Rf value, melting point and 
percentage of yield for all the synthesized compounds of MBH series are given in 
Table 3.1. 
 The characterization was done by IR, 1H NMR and mass spectra. 
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Table 3.1: Physical constants of compounds of MBH series. 
 
Sr. No. Code R M.F. 
M. Wt. 
g 
Rf* 
Value 
M.P. 
oC 
Yield 
% 
1 MBH 1 4-OCH3, 3-OH- C17H17N3O2 295.4 0.42 218 65 
2 MBH 2 4-OCH3- C17H17N3O 279.4 0.35 258 63 
3 MBH 3 4-OH- C16H15N3O 265.3 0.48 230 64 
4 MBH 4 4-Cl- C16H14ClN3 283.8 0.45 210 73 
5 MBH 5 3-Cl- C16H14ClN3 283.8 0.28 205 68 
6 MBH 6 4-F- C16H14FN3 267.3 0.34 202 69 
7 MBH 7 3-NO2- C16H14N4O2 294.3 0.56 210 78 
8 MBH 8 H- C16H15N3 249.3 0.50 222 65 
9 MBH 9 3, 4-Di OCH3- C18H19N3O2 309.4 0.39 195 58 
10 MBH 10 4-N, N-Di CH3- C18H20N4 292.4 0.30 188 61 
* Ethyl acetate :Hexane : 3:7 
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Table 3.3: IR spectral data of other synthesized tetrahydroquinollines. 
 
Compounds 
IR ν, (cm-1) 
C=C str C=N str N-H str C≡N str 
MBH 2 1530.15 1672.56 3459.41 2215.32 
MBH 3 1523.01 1665.32 3466.23 2211.54 
MBH 4 1528.32 1675.19 3468.55 2215.26 
MBH 5 1522.16 1671.87 3475.89 2218.51 
MBH 6 1519.56 1670.54 3468.15 2209.33 
MBH 7 1532.17 1672.33 3471.23 2212.12 
MBH 8 1511.11 1672.45 3475.15 2205.14 
MBH 9 1525.32 1673.26 3472.26 2213.94 
MBH 10 1522.23 1674.54 3470.02 2209.09 
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Table 3.4: 1H NMR spectral data of 2-amino-4-(4-hydroxy-3-methoxy 
phenyl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile (MBH 1). 
       
Signal 
No. 
Signal 
Position 
(δ ppm) 
Relative No. 
of Protons 
Multiplicity Inference 
J 
(Hz) 
1 1.56-1.58 2 multiplet -CH2- (b) - 
2 1.70-1.74 2 multiplet -CH2- (c) - 
3 2.26-2.29 2 triplet -CH2- (d) - 
4 2.55-2.69 2 triplet -CH2- (a) - 
5 3.75 3 singlet -OCH3 (h) - 
6 5.16 1 singlet -OH (g) - 
7 6.48 2 singlet -NH2 (j) - 
8 6.65-6.67 1 doublet Ar-Hf  6.24 
9 6.82-6.87 2 multiplet Ar-He, i - 
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igure 3.3: Mass spectra of 2-amino-4-(4-hydroxy-3-me
 
thoxyphenyl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile (MBH 1). 
P
a
g
e
4
3
 
  
P
a
g
e
4
4
 
N
N
NH2
OH
O
N
C
+
N
NH2
O
m/z=278
N
C
+
N
NH2
OH
m/z=264
N
N
OH
OH
m/z=235
m/z=111
N
NH2 NH2
m/z=81
m/z=85
CH2
+
CH2
+
m/z=295
m/z=57
+.
+.
+.
+.
+.
+.
+.
Scheme 3.1: Proposed mass fragmentation of 2-amino-4-(4-hydroxy-3-methoxyphenyl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile (MBH 1). 
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   SYNTHESIS AND CHARACTERIZATION 
Synthesis of 5-(4-aryl)-6,7,8,9-tetrahydropyrimido[4,5-b] quinolin-4(3H)-
one: 
 
To a solution of 2-amino-4-aryl-5,6,7,8-tetrahydroquinoline-3-carbonitrile in 
formic acid, 2-3 drops of H2SO4 was added and the solution mixture was 
refluxed for 4 hours in a water bath. The product was isolated from the 
reaction mass and recrystalised from methanol. 
Reaction Scheme: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N
NH
N
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N
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Following compounds were synthesized through above reaction scheme: 
MBD 1:  5-(4-hydroxy-3-methoxyphenyl)-6,7,8,9-tetrahydropyrimido[4,5-b] 
quinolin-4(3H)-one 
MBD 2:  5-(4-methoxyphenyl)-6,7,8,9-tetrahydropyrimido[4,5-b]quinolin-4 
(3H)-one 
MBD 3:  5-(4-hydroxyphenyl)-6,7,8,9-tetrahydropyrimido[4,5-b]quinolin-4 
(3H)-one 
MBD 4:  5-(4-chlorophenyl)-6,7,8,9-tetrahydropyrimido[4,5-b]quinolin-4(3H) 
-one 
MBD 5:  5-(3-chlorophenyl)-6,7,8,9-tetrahydropyrimido[4,5-b]quinolin-4(3H) 
-one 
MBD 6:  5-(4-fluorophenyl)-6,7,8,9-tetrahydropyrimido[4,5-b]quinolin-4(3H)-
one 
MBD 7:  5-(3-nitrophenyl)-6,7,8,9-tetrahydropyrimido[4,5-b]quinolin-4(3H)-
one 
MBD 8:  5-phenyl-6,7,8,9-tetrahydropyrimido[4,5-b]quinolin-4(3H)-one 
MBD 9: 5-(3,4-dimethoxyphenyl)-6,7,8,9-tetrahydropyrimido[4,5-b]quinolin 
-4(3H)-one 
MBD 10: 5-[4-(dimethylamino)phenyl]-6,7,8,9-tetrahydropyrimido[4,5-b]quin 
olin-4(3H)-one 
  
 The various physical constants such as Rf value, melting point and 
percentage of yield for all the synthesized tetrahydropyrimidines are given in 
Table 4.1. 
 The characterization was done by IR, 1H NMR and mass spectra. 
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Table 4.1: Physical constants of compounds of MBD series. 
Sr. No. Code R M.F. 
M. Wt. 
g 
Rf* 
Value 
M.P. 
oC 
Yield 
% 
1 MBD 1 4-OCH3, 3-OH- C18H17N3O3 323.4 0.25 118 45 
2 MBD 2 4-OCH3- C18H17N3O2 307.4 0.15 122 42 
3 MBD 3 4-OH- C17H15N3O2 293.3 0.21 125 45 
4 MBD 4 4-Cl- C17H14ClN3O 311.8 0.33 109 43 
5 MBD 5 3-Cl- C17H14ClN3O 311.8 0.26 105 40 
6 MBD 6 4-F- C17H14FN3O 295.3 0.38 130 38 
7 MBD 7 3-NO2- C17H14N4O3 322.3 0.45 113 41 
8 MBD 8 H- C17H15N3O 277.3 0.30 129 49 
9 MBD 9 3, 4-Di OCH3- C19H19N3O3 337.4 0.22 104 45 
10 MBD 10 4-N, N-Di CH3- C19H20N4O 320.4 0.31 99 41 
* Ethyl acetate :Hexane : 5:5 
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Table 4.3: IR spectral data of other synthesized tetrahydroquinoline -
pyrimidine. 
Compounds 
IR ν, (cm-1) 
C=C str C=N str N-H str 
C=O str 
(Cyclic) 
MBD 2 1513.13 1640.04 3127.22 1701.17 
MBD 3 1519.15 1641.25 3129.91 1690.15 
MBD 4 1514.12 1642.25 3131.35 1708.22 
MBD 5 1512.55 1641.52 3130.84 1695.25 
MBD 6 1511.11 1642.23 3125.21 1694.98 
MBD 7 1512.45 1642.88 3124.24 1700.99 
MBD 8 1513.35 1640.54 3126.36 1699.02 
MBD 9 1514.41 1639.39 3129.28 1705.04 
MBD 10 1509.09 1639.98 3127.61 1695.07 
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Table 4.4: 1H NMR spectral data of 5-(4-hydroxy-3-methoxyphenyl)-
6,7,8,9-tetrahydropyrimido[4,5-b]quinolin-4(3H)-one (MBD 1). 
Singal 
No. 
Signal 
Position 
(δ ppm) 
Relative No. 
of Protons 
Multiplicity Inference 
J 
(Hz) 
1 1.13-1.30 2 multiplet -CH2-(b) - 
2 1.81-1.86 2 multiplet -CH2-(c) - 
3 2.24-2.39 2 triplet -CH2-(d) - 
4 2.80-2.84 2 triplet -CH2-(a) - 
5 3.92 3 singlet -OCH3 (f) - 
6 5.07 1 singlet -OH (g) - 
7 6.75-6.79 2 doublet Ar-H h, i 11.1 
8 6.99-7.02 1 doublet Ar-H e 7.9 
9 7.27 1 singlet -NH (j) - 
10 8.22 1 singlet Ar-H k - 
 F
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
igure 4.3: Mass spectra of 5-(4-hydroxy-3-methoxyphenyl)-6,7,8,9-tetrahydropyrimido[4,5-b]quinolin-4(3H)-one (MBD 1). 
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Scheme 4.1: Proposed mass fragmentation of 5-(4-hydroxy-3-methoxyphenyl)-6,7,8,9-tetrahydropyrimido[4,5-b]quinolin-
4(3H)-one (MBD 1). 
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         INTRODUCTION 
          Benzimidazoles have been widely used since the 1960s as potent, orally 
active, safe, broad-spectrum anthelmintics agents in veterinary and human 
medicine and as antifungal agents in agriculture. Recently some drugs with 
benzimidazole ring system also used as antihistaminic, antiulcerative, 
protonpumpinhibitor, antiemetic etc. Mebendazole, thiabendazole, lobendazole, 
astemizole, omeprazpole, lansopraazole, domperidoone etc. are the some 
examples of drugs which possess benzimidazoole ring system. Maribavir, a 
novel antiviral agent in the benzimidazole drug class (1) which is currently in 
clinical development (2), have the potency to be used for the prevention of 
cytomegalovirus infections in transplant patients.   
 Compounds of benzimidazole class are efficient inhibitors of different 
biological processes (3, 11-13). This is further confirmed by Fellenius et al.  in 
rabbits (4) and by Sewing et al.  in guinea pig (5). Wooley et al have checked the 
biological effect caused by benzimidazole (6). These derivatives also inhibit 
microtubule polymerization in vitro and in vivo in a similar fashion (7-10). 
 Benzimidazoles are known to possess various biological activities like 
antiprotozoal (14-17), antimicrobial (18, 19), antifungal (20, 21), antibacterial (20, 22, 23), 
antimicrotubule (24), antiproliferative (25), anti viral (26), anti HIV (27, 28) or 
fasciolicidal activity (29). Literature survey shows that various chemists have 
synthesized derivatives of benzimidazoles (16, 30-34). Most of them also evaluated 
synthesized compounds for different biological activities (35- 37). 
 Coumarin, a simple molecule, and its derivatives, have been known for 
more than a century. This class of compounds are known to prevent diseases, 
modulates growth and maturation and defence systems and may have anti-
oxidant properties (38). Various coumarin derivatives can be extracted from many 
natural products (39, 40). These extracts shows anti HIV (41), antinoceceptive (42), 
antinflammatory (43), bronchodilator (44), anti oxidative (45) etc. activities. 
Therefore, coumarins always attract chemists to synthesize derivatives as 
precursor of novel drug. Such synthesized modified coumarins are noted to show 
various activities like anticarcenogenic (46), antimicrobial (47), antifungal (48), 
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antibacterial (49), antioxidant (50, 51), antiinfalammatory (52) etc. It is also used to 
inhibit many biological processes also (53-57). So, chemists have regularly 
synthesized differently modified coumarins by applying variable conditions (58-65). 
 In this part, an attempt has made to synthesize compounds with the 
properties of both the moieties viz. benzimidazole and coumarin. In this section 
some derivatives of benzimidazoles have condenced with acetyl coumarin. 
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      SYNTHESIS AND CHARACTERIZATION 
Synthesis of 3-{[2-(4-aryl)-1H-benzimidazol-1-yl]acetyl}-2H-chromen-2-one 
Synthesis of 2-(4-aryl)-1H-benzimidazole: 
 o-phenelinediamine (1.08 gm, 0.01 M) and aromatic aldehydes (1.52 gm, 
0.01) were dissolved in appropriate amount of metheline dichloride (MDC). To 
this clear solution, 0.005 M of cerric ammonium nitrate (CAN) (2.74 gm) was 
added with constant stirring. The reaction mixture was stirred for 10-15 minutes 
and completion of reaction was checked with TLC in appropriate solvent system. 
After the completion of reaction, solvent was evaporated by rota vapour and 
residue was recrystallized from methanol. 
Reaction Scheme: 
                                             
 
 
 
 
Synthesis of 3-(bromoacetyl)-2H-chromen-2-one: 
Synthesis of 3-acetyl-2H-chromen-2-one: 
 To synthesize acetyl derivative coumarin, salicyldehyde (1.22 gm, 0.01M) 
and equivalent amount of ethyl aceto acetate (1.30 gms, 0.01M) was dissolved in 
methanol. The reaction mixture was stirred for 10 minutes after adding 2-3 drops 
of piperidin as catalyst. After completion of reaction (as observed by TLC), the 
mass was poured to the crushed ice. The product was extracted from solution 
with ethyl acetate. The solvent was evaporated and the crude product was 
recrystallized  from ethanol. 
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Reaction Scheme: 
 
          
                                                                                                                                                      
 
 
Bromination of 3-acetyl-2H-chromen-2-one: 
 The above product i.e., 3-acetyl-2H-chromen-2-one (1.88 gm, 0.01M) was 
dissolved in chloroform. To this solution, bromine solution (1.6 ml, 0.01M) in 
chloroform was added drop wise and temperature was maintained at about 0-50 
C. After the addition of bromine solution, the solution was stirred at room 
temperature for half an hour. The resulting product was filtered and recrystallized 
from ethanol. 
Reaction Scheme: 
 
  
 
 
 
Condensation of 2-(4-aryl)-1H-benzimidazoles with 3-(bromoacetyl)-2H-
chromen-2-one. 
 Equimolar amount of 2-(4-aryl)-1H-benzimidazoles with 3-(bromoacetyl)-
2H-chromen-2-one was dissolved in the minimum amount of solvent. Small 
amount of sodium hydroxide was added to the solution and stirred by magnetic 
stirrer for about 3-4 hours. After completion of reaction, the product was 
extracted in ethyl acetate. The solution was evaporated to dryness and was 
recrystallized from ethanol. 
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Following compounds were synthesized through above reaction scheme: 
MBB 1:  3-{[2-(4-hydroxy-3-methoxyphenyl)-1H-benzimidazol-1-yl]acetyl}-2H-
chromen-2-one 
MBB 2:  3-{[2-(4-methoxyphenyl)-1H-benzimidazol-1-yl]acetyl}-2H-chromen-
2-one 
MBB 3:  3-{[2-(4-hydroxyphenyl)-1H-benzimidazol-1-yl]acetyl}-2H-chromen-2-
one 
MBB 4:  3-{[2-(4-chlorophenyl)-1H-benzimidazol-1-yl]acetyl}-2H-chromen-2-
one 
MBB 5:  3-{[2-(3-chlorophenyl)-1H-benzimidazol-1-yl]acetyl}-2H-chromen-2-
one 
MBB 6:  3-{[2-(4-fluorophenyl)-1H-benzimidazol-1-yl]acetyl}-2H-chromen-2-
one 
MBB 7:  3-{[2-(3-nitrophenyl)-1H-benzimidazol-1-yl]acetyl}-2H-chromen-2-
one 
MBB 8:  3-[(2-phenyl-1H-benzimidazol-1-yl)acetyl]-2H-chromen-2-one 
MBB 9: 3-{[2-(3,4-dimethoxyphenyl)-1H-benzimidazol-1-yl]acetyl}-2H-
chromen-2-one 
MBB 10: 3-{[2-[4-(dimethylamino)phenyl]-1H-benzimidazol-1-yl]acetyl}-2H-
chromen-2-one 
  
 The various physical constants such as Rf value, melting point and 
percentage of yield for all the synthesized tetrahydropyrimidines are given in 
Table 5.1. 
 The characterization was done by IR, 1H NMR and mass spectra. 
 
 
    
 
 
 
 
 P
a
g
e
5
4
 
Table 5.1: Physical constants of compounds of MBB series. 
Sr. No. Code R M.F. 
M. Wt. 
g 
Rf* 
Value 
M.P. 
oC 
Yield 
% 
1 MBB 1 4-OCH3, 3-OH- C26H20N2O3 408.5 0.35 278 45 
2 MBB 2 4-OCH3- C26H20N2O2 392.5 0.32 265 49 
3 MBB 3 4-OH- C25H18N2O2 378.4 0.38 305 52 
4 MBB 4 4-Cl- C25H17ClN2 396.9 0.25 315 41 
5 MBB 5 3-Cl- C25H17ClN2O 396.9 0.19 322 40 
6 MBB 6 4-F- C25H17FN2O 380.4 0.22 299 53 
7 MBB 7 3-NO2- C25H18N2O 362.4 0.41 329 43 
8 MBB 8 H- C25H18N2O 362.4 0.29 285 54 
9 MBB 9 3, 4-Di OCH3- C27H22N2O3 422.5 0.30 255 39 
10 MBB 10 4-N, N-Di CH3- C27H23N3O 405.5 0.27 335 32 
* Methanol : Hexane : 5:5 
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Table 5.3: IR spectral data of other synthesized benzimidazole derivatives. 
 
Compounds 
IR ν, (cm-1) 
C=C str 
C=O str 
(cyclic) 
C=O str 
(aliphatic) 
C-N str 
MBB 2 1515.11 1717.21 1615.03 1260.12 
MBB 3 1525.44 1721,21 1622.12 1262.28 
MBB 4 1528.02 1728.01 1625.12 1269.13 
MBB 5 1499.71 1722.15 1608.02 1260.62 
MBB 6 1524.12 1725.14 1615.39 1264.33 
MBB 7 1520.23 1730.11 1613.19 1264.11 
MBB 8 1546.17 1719.00 1611.28 1259.23 
MBB 9 1505.79 1722.23 1610.22 1259.35 
MBB 10 1517.32 1705.14 1601.59 1260.60 
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Table 5.4: 1H NMR spectral data of 3-{[2-(4-hydroxy-3-methoxyphenyl)-1H-
benzimidazol-1-yl]acetyl}-2H-chromen-2-one (MBB 1). 
Signal 
No. 
Signal 
Position 
(δ ppm) 
Relative No. 
of Protons 
Multiplicity Inference 
J 
(Hz) 
1 3.74 3 singlet -OCH3 (a) - 
2 5.15 1 singlet -OH (b) - 
3 5.65 2 singlet -CH2- (h) - 
4 6.53-6.56 1 doublet Ar-Hc 7.55 
5 6.70-6.71 1 doublet Ar-Hd 3.27 
6 6.81-6.96 1 
double 
doublet 
Ar-He 
6.60 
3.91 
7 7.31-7.39 4 multiplet Ar-Hj,k,l,m - 
8 7.71-7.73 2 multiplet Ar-Hgg’  
9 7.78-7.79 2 multiplet Ar-Hff’  
10 8.5 1 singlet Ar-Hi - 
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igure 5.3: Mass spectra of 3-{[2-(4-hydroxy-3-methoxyphenyl)-1H-benzimidazol-1-yl]acetyl}-2H-chromen-2-one (MBB 1).  
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Scheme 5.1: Proposed mass fragmentation of 3-{[2-(4-hydroxy-3-methoxyphenyl)-1H-benzimidazol-1-yl]acetyl}-2H-
chromen-2-one (MBB 1).   
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  INTRODUCTION 
 Ultrasonic studies deals with the waves of frequency above the range audible 
to the human ear, i.e., approximately 20, 000 Hertz. 
 Ultrasonic radiation is useful towards many directions of sciences. Ultrasonic 
waves are useful in industries for different physical treatments of industrially 
useful materials like agitation (1), dispersion (2), emulsification (3) etc. Ultrasound 
waves have also been used for cleaning (4) and to repair cracks (5).  
 Various researchers have checked the effect of ultrasound on human serum 
gamma globulin (6), aqueous solution of cytosine (7), other nucleic acid 
components (8). Ultrasound is also useful as an aid for the extraction method of 
separating lutein from tagetes erecta flower (9). Zhu et al. have improved the 
sludge's aerobic digestibility by ultrasonic treatment.  Further, the digestion time 
was shortened (10) due to ultrasonic treatment. Ultrasonic rays are useful tool in 
medical field also. Ultrasonic radio-frequency spectrum analysis differentiates 
normal and edematous brain tissue from meningioma Intraoperatively (11). It is 
also used for various diagnosis such as paediatrics (12, 13), vascular diseases (14, 
15), brain diseases (16), ophthalmology (17, 18), in urology (19, 20), in cancer cell (21, 22) 
etc. Organic materials in landfill can also be degraded by ultrasound (23). 
Pharmaceutical products are often present in wastewater treatment effluents, 
rivers, lakes and more rarely, in groundwater which can be treated by sonolysis 
(24). It is also applied for inactivation of micro-organisms in food (25-27) and dairy 
industry (28-30).  
 Recently, a lot of interest has been generated on the use of ultrasound 
radiation in synthetic organic chemistry, because of its salient features like less 
reaction time, higher percentage of yield, lower reaction temperature, avoidance 
of phase transfer catalysis etc (31-36), which are compatible with green chemistry 
approach.  
 The structure of molecules and intermolecular attraction between 
molecules can be well understood through various thermodynamic parameters 
calculated through ultrasonic velocity measurements (37). 
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 These ultrasonic measurements have been done for various pure liquids 
(38-40), liquid mixtures (41-44) and solutions of organic and inorganic compounds (45, 
47), polymers (48), amino acids (49), drugs (50, 51) etc. The studies in some liquid 
crystals have also been done by Ayachit et al. (52).  
 In our laboratory, the ultrasonic studies of some compounds like Schiff bases 
(53), benzodiazepines (54), dihydropyrimidines (55) etc have been studied in 
different solvents. 
        In the present section, ultrasonic studies of compounds of MDT series have 
been studied in N, N dimethylformamide and chloroform solutions of various 
concentrations at 303.15 K with a view to understand molecular interactions in 
these solutions. 
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                               EXPERIMENTAL 
Choice of Solvents: 
 N, N-Dimethylformamide (DMF) and chloroform (CHCl3) have been 
chosen as solvents with different polarity and dielectric constants in the present 
work. These two solvents are of industrial interest because of their wide use as 
solvents and solubilising agents. These solvents are distilled by the reported 
procedure (56). 
 The densities, viscosities and ultrasonic velocities of solvents and 
solutions of tetrahydropyrimidines of different concentrations were measured at 
303.15 K by using pyknometer, an Ubbelohde suspended level viscometer and 
single frequency ultrasonic interferometer operating at 2 MHz, with the 
uncertainties of 0.0001 g/cm3, + 0.06 % and 0.01% respectively. 
Density measurements: 
              The weight of distilled water, pure solvents and solutions were 
measured by using pyknometer. The densities were evaluated by using following 
equation: 
  
( ) ( )( )( )3 wt. of solvent or solution density of waterρ g cm = wt. of water     ... 
(3.1.1) 
Viscosity Measurements: 
           To determine the viscosity of solution, Ubbelohde viscometer
 (57)
 was 
used, which obeys Stoke’s low
 (58)
. The measured quantity of the distilled water / 
solvent / solution was placed in the viscometer, which was suspended in a 
thermostat at 303.15 K. The digital stopwatch, with an accuracy of + 0.01 sec 
was used to determine flow time of solutions. Using the flow times (t) and known 
viscosity of standard water sample, the viscosity of solvent and solutions were 
determined according to equation: 
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                  1 1 1
2 2 2
t
t
η ρ
η ρ=                                          ... (3.1.2) 
Sound velocity measurement:  
                 Ultrasonic interferometer (Model No. F-81), Mittal Enterprise, New 
Delhi, working at frequency (F) of 2 MHz was used to determine sound velocity. 
                  The solvent / solution were filled in the measuring cell with quartz 
crystal and then micrometer was fixed. The circulation of water from the 
thermostat at 303.15 K was started and test solvent / solution in the cell is 
allowed to thermally equilibrate. The micrometer was rotated very slowly so as to 
obtain a maximum or minimum of anode current (n). A number of maximum 
reading of anode current were counted. The total distance (d) travel by the 
micrometer for n=10, was read. The wave length (λ) was determined according 
to the equation (3.1.3). 
                                         
2d
n
λ =                  … (3.1.3) 
               The sound velocity (U) of solvent and solutions were calculated from 
the wavelength and frequency (F) according to equation (3.1.4). 
                                                 U Fλ=           ... (3.1.4) 
 In the present study, frequency F is 2 MHz. 
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   RESULTS AND DISCUSSION 
         Tables 3.1.1 and 3.1.2 shows the experimental data of density (ρ), sound 
velocity (U) and viscosity (η) of pure solvents and solutions of synthesized 
compounds (MDT series) in DMF and chloroform at 303.15 K.  
         From these experimental data, various acoustical parameters like Specific 
acoustical impedance (Z), isentropic compressibility (κs), intermolecular free 
length (Lf), molar compressibility (W), Rao’s molar sound function (Rm), Vander 
Waals constant (b), relaxation strength (r), solvation number (π), etc., were 
evaluated using the following equations: 
1.  Specific acoustical impedance: 
          Specific acoustical impedance (Z) can be calculated as: 
     Z Uρ=           … (3.1.5) 
2.  Isentropic compressibility: 
         Isentropic compressibility ( sκ ) can be evaluated by the equation (59):  
     2
1
s U
κ ρ=           … (3.1.6) 
3.  Intermolecular free path length: 
 Jacobson (60) proposed an equation to calculate the intermolecular free 
path length (Lf), which is given below: 
     1 2f j sL K κ=             … (3.1.7) 
where KJ is Jacobson constant (=2.0965 X 10
-6)   
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Table 3.1.1: The density (ρ), ultrasonic velocity (U) and viscosity (η) of MDT series in DMF at 303.15 K. 
 
conc. MDT 1 MDT 2 MDT 3 MDT 4 MDT 5 MDT 6 MDT 7 MDT 8 MDT 9 MDT 10 
Density (ρ) (g.cm-3) 
0.00 0.9416 0.9416 0.9416 0.9416 0.9416 0.9416 0.9416 0.9416 0.9416 0.9416 
0.01 0.9456 0.9448 0.9486 0.9494 0.9494 0.9454 0.9529 0.9507 0.9424 0.9562 
0.02 0.9465 0.9452 0.9489 0.9503 0.9503 0.9458 0.9530 0.9507 0.9429 0.9565 
0.04 0.9483 0.9461 0.9495 0.9520 0.9520 0.9467 0.9531 0.9508 0.9440 0.9571 
0.06 0.9500 0.9470 0.9501 0.9538 0.9538 0.9476 0.9532 0.9509 0.9451 0.9576 
0.08 0.9517 0.9479 0.9507 0.9555 0.9556 0.9484 0.9533 0.9510 0.9462 0.9581 
0.10 0.9535 0.9489 0.9513 0.9573 0.9573 0.9494 0.9534 0.9511 0.9473 0.9587 
Velocity (U.10-5) (cm.s-1) 
0.00 1.4480 1.4480 1.4480 1.4480 1.4480 1.4480 1.4480 1.4480 1.4480 1.4480 
0.01 1.4524 1.4584 1.4732 1.4544 1.4704 1.4520 1.4680 1.4712 1.4780 1.4696 
0.02 1.4536 1.4560 1.4712 1.4556 1.4680 1.4524 1.4660 1.4704 1.4760 1.4716 
0.04 1.4568 1.4540 1.4672 1.4584 1.4632 1.4540 1.4632 1.4696 1.4724 1.4764 
0.06 1.4600 1.4520 1.4636 1.4612 1.4588 1.4552 1.4604 1.4688 1.4684 1.4808 
0.08 1.4632 1.4496 1.4596 1.4640 1.4540 1.4564 1.4572 1.4680 1.4648 1.4852 
0.10 1.4664 1.4488 1.4560 1.4672 1.4496 1.4580 1.4544 1.4672 1.4612 1.4900 
Viscosity (η.103) ( poise) 
0.00 5.7591 5.7591 5.7591 5.7591 5.7591 5.7591 5.7591 5.7591 5.7591 5.7591 
0.01 6.0744 5.9308 6.7249 6.3664 6.9830 6.0309 6.3515 6.7800 5.7923 8.0902 
0.02 6.2141 6.0389 6.7819 6.4059 7.0560 6.1333 6.4292 6.8123 5.8737 8.1222 
0.04 6.4940 6.2506 6.8952 6.4868 7.2038 6.3404 6.5914 6.8787 6.0386 8.1880 
0.06 6.7758 6.4651 7.0102 6.5671 7.3513 6.5466 6.7517 6.9442 6.2031 8.2537 
0.08 7.0577 6.6784 7.1253 6.6485 7.5003 6.7541 6.9113 7.0105 6.3687 8.3197 
0.10 7.3415 6.8938 7.2390 6.7301 7.6496 6.9622 7.0718 7.0769 6.5347 8.3856 
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Table 3.1.2: The density (ρ), ultrasonic velocity (U) and viscosity (η) of MDT series in chloroform at 303.15 K. 
conc. MDT 1 MDT 2 MDT 3 MDT 4 MDT 5 MDT 6 MDT 7 MDT 8 MDT 9 MDT 10 
Density (ρ) (g.cm-3) 
0.00 1.4713 1.4713 1.4713 1.4713 1.4713 1.4713 1.4713 1.4713 1.4713 1.4713 
0.01 1.4713 1.4717 1.4714 1.4749 1.4720 1.4747 1.4800 1.4735 1.4809 1.4746 
0.02 1.4715 1.4724 1.4718 1.4753 1.4723 1.4752 1.4801 1.4737 1.4813 1.4751 
0.04 1.4721 1.4736 1.4727 1.4761 1.4730 1.4762 1.4803 1.4741 1.4820 1.4763 
0.06 1.4726 1.4749 1.4736 1.4768 1.4736 1.4772 1.4805 1.4744 1.4827 1.4775 
0.08 1.4731 1.4761 1.4745 1.4776 1.4743 1.4782 1.4807 1.4748 1.4834 1.4787 
0.10 1.4737 1.4774 1.4754 1.4784 1.4750 1.4792 1.4809 1.4751 1.4841 1.4798 
Velocity (U.10-5) (cm.s-1) 
0.00 0.9640 0.9640 0.9640 0.9640 0.9640 0.9640 0.9640 0.9640 0.9640 0.9640 
0.01 0.9664 0.9676 0.9672 0.9652 0.9668 0.9688 0.9676 0.9644 0.9644 0.9648 
0.02 0.9668 0.9680 0.9680 0.9652 0.9668 0.9692 0.9680 0.9656 0.9652 0.9652 
0.04 0.9684 0.9692 0.9696 0.9660 0.9672 0.9700 0.9688 0.9684 0.9668 0.9668 
0.06 0.9700 0.9704 0.9716 0.9664 0.9676 0.9708 0.9696 0.9712 0.9688 0.9680 
0.08 0.9716 0.9716 0.9732 0.9668 0.9680 0.9716 0.9704 0.9740 0.9704 0.9692 
0.10 0.9732 0.9732 0.9752 0.9676 0.9684 0.9724 0.9716 0.9772 0.9724 0.9708 
Viscosity (η.103) ( poise) 
0.00 20.7089 20.7089 20.7089 20.7089 20.7089 20.7089 20.7089 20.7089 20.7089 20.7089 
0.01 29.0267 25.0234 26.0483 21.8259 21.3105 23.0004 21.2244 21.6914 21.6108 21.1902 
0.02 30.2016 25.7452 27.3834 21.9701 21.4286 23.1473 22.0103 21.8389 23.0529 21.2239 
0.04 32.5657 27.1960 30.0553 22.2716 21.6773 23.4406 23.5944 22.1467 25.9390 21.3038 
0.06 34.9243 28.6437 32.7309 22.5672 21.9200 23.7406 25.1727 22.4480 28.8277 21.3774 
0.08 37.2851 30.0998 35.4092 22.8630 22.1632 24.0345 26.7513 22.7500 31.7197 21.4576 
0.10 39.6539 31.5585 38.0973 23.1652 22.4128 24.3354 28.3369 23.0581 34.6200 21.5378 
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4.  Molar compressibility: 
          Molar compressibility (W) can be calculated by the following equation 
(61)
: 
     1 7s
MW κρ
−⎛ ⎞= ⎜ ⎟⎝ ⎠
         … (3.1.8) 
The apparent molecular weight (M) of the solution can be calculated according to 
equation (3.1.8): 
     1 1 2 2M M W M W= +          … (3.1.9) 
where W1 and W2 are weight fractions of solvent and solute, respectively. M1 
and M2 are the molecular weights of the solvent and compounds respectively.  
5.  Rao’s molar sound function: 
          Rao’s molar sound function (Rm) can be evaluated by an equation given 
by Bagchi et al. 
(62)
: 
              1 3m
MR Uρ
⎛ ⎞= ⎜ ⎟⎝ ⎠
                         … (3.1.10) 
6.  Van der Waals Constant: 
          Van der Waals constant (b) can be calculated as follows (63): 
           
2
21 1 13
M RT MUb
MU RTρ
⎧ ⎫⎡ ⎤⎪ ⎪⎛ ⎞= − + −⎢ ⎥⎨ ⎬⎜ ⎟⎝ ⎠ ⎢ ⎥⎪ ⎪⎣ ⎦⎩ ⎭
       ... (3.1.11) 
where R is the gas constant (=8.3143 JK-1 mol-1) and T is the absolute 
temperature. 
7.  Relaxation Strength: 
          The relaxation strength (r) can be calculated as follows (64): 
    
2
1r U
U
= −
∞
⎡ ⎤⎢ ⎥⎣ ⎦
                                     … (3.1.12) 
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where ∞U  = 1.6 x 105 cm/sec.  
8. Solvation number:  
                                    
2
1 1
1 100s
n
s
M XS
M X
κ
κ
⎡ ⎤− −⎡ ⎤= ⎢ ⎥ ⎢ ⎥⎣ ⎦⎣ ⎦  
                  … (3.1.13) 
where X is the number of grams of solute in 100 gm of the solution. M1 and M2 
are the molecular weights and κS1 and κS are isentropic compressibility of solvent 
and solute respectively. 
 Figures 3.1.1 and 3.1.2 show the variation of ultrasound velocity (U) with 
concentration for compounds of MDT series in both the solvents. It is observed 
that in DMF (Figure 3.1.1), for MDT-1, MDT-4, MDT-6 and MDT-10, ultrasonic 
velocity increases with concentration whereas for MDT-2, MDT-3, MDT-5, MDT-
7, MDT-8 and MDT-9 ultrasonic velocity decreases with concentration. The 
velocity depends on intermolecular free length (Lf). The velocity increases with 
decrease in Lf or vice versa. This fact is clearly shown in Table 3.1.3 for DMF. 
The Lf value decreases with concentration for MDT-1, MDT-4, MDT-6 and MDT-
10 whereas for MDT-2, MDT-3, MDT-5, MDT-7, MDT-8 and MDT-9, it increases. 
The increase of U and decrease of Lf in solutions of MDT-1, MDT-4, MDT-6 and 
MDT-10, suggests that the solvent molecules interact strongly with compound 
molecules. Thus, ion-solvent (or solute-solvent) interactions predominate in 
these systems. However, in DMF solutions of MDT-2, MDT-3, MDT-5, MDT-7, 
MDT-8 and MDT-9, the increase on intermolecular free path length and decrease 
of ultrasonic velocity suggest the dominance of solute-solute interactions in these 
systems.   
 In chloroform solutions, velocity increases with concentration for all the 
studied compounds, as shown in Figure 3.1.2 whereas Lf values for all the 
compounds decreases with concentration (Table 3.1.4). Thus, in chloroform 
solutions also, solvent molecules interact strongly with all the compound 
molecules in all the systems.  
 This is further supported by isentropic compressibility (κs) and relaxation 
strength (r). The variation of isentropic compressibility (κs) with concentration of  
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Table 3.1.3: Some acoustical parameters of MDT series in DMF at 303.15 K.   
conc. MDT 1 MDT 2 MDT 3 MDT 4 MDT 5 MDT 6 MDT 7 MDT 8 MDT 9 MDT 10 
Specific Acoustical Impedence (Z.105) (g.cm-2)
0.00 1.3635 1.3635 1.3635 1.3635 1.3635 1.3635 1.3635 1.3635 1.3635 1.3635 
0.01 1.3735 1.3778 1.3975 1.3808 1.3960 1.3727 1.3989 1.3987 1.3929 1.4053 
0.02 1.3759 1.3762 1.3960 1.3832 1.3950 1.3737 1.3971 1.3980 1.3918 1.4076 
0.04 1.3814 1.3757 1.3931 1.3884 1.3930 1.3765 1.3946 1.3974 1.3900 1.4130 
0.06 1.3870 1.3751 1.3905 1.3936 1.3914 1.3789 1.3921 1.3967 1.3878 1.4180 
0.08 1.3926 1.3741 1.3876 1.3989 1.3894 1.3813 1.3892 1.3961 1.3860 1.4230 
0.10 1.3982 1.3747 1.3850 1.4045 1.3877 1.3842 1.3866 1.3955 1.3842 1.4284 
Intermolecular free path length (Lf) (A0) 
0.00 0.1492 0.1492 0.1492 0.1492 0.1492 0.1492 0.1492 0.1492 0.1492 0.1492 
0.01 0.1484 0.1479 0.1461 0.1479 0.1463 0.1485 0.1463 0.1462 0.1461 0.1459 
0.02 0.1482 0.1481 0.1463 0.1478 0.1465 0.1484 0.1465 0.1462 0.1463 0.1457 
0.04 0.1478 0.1482 0.1466 0.1473 0.1468 0.1482 0.1468 0.1463 0.1465 0.1452 
0.06 0.1473 0.1484 0.1470 0.1469 0.1472 0.1480 0.1470 0.1464 0.1469 0.1447 
0.08 0.1469 0.1485 0.1473 0.1465 0.1475 0.1478 0.1474 0.1464 0.1471 0.1442 
0.10 0.1464 0.1486 0.1476 0.1460 0.1478 0.1476 0.1476 0.1465 0.1474 0.1437 
Relaxation Strength (r) 
0.00 0.1810 0.1810 0.1810 0.1810 0.1810 0.1810 0.1810 0.1810 0.1810 0.1810 
0.01 0.1760 0.1692 0.1522 0.1737 0.1554 0.1764 0.1582 0.1545 0.1467 0.1564 
0.02 0.1746 0.1719 0.1545 0.1724 0.1582 0.1760 0.1605 0.1554 0.1490 0.1541 
0.04 0.1710 0.1742 0.1591 0.1692 0.1637 0.1742 0.1637 0.1564 0.1531 0.1485 
0.06 0.1673 0.1764 0.1632 0.1660 0.1687 0.1728 0.1669 0.1573 0.1577 0.1434 
0.08 0.1637 0.1792 0.1678 0.1628 0.1742 0.1714 0.1705 0.1582 0.1619 0.1384 
0.10 0.1600 0.1801 0.1719 0.1591 0.1792 0.1696 0.1737 0.1591 0.1660 0.1328 
                
 Contd... 
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conc. MDT 1 MDT 2 MDT 3 MDT 4 MDT 5 MDT 6 MDT 7 MDT 8 MDT 9 MDT 10 
Molar compressibility (W.10-3) (cm-1. dyn-1) 
0.00 2.2948 2.2948 2.2948 2.2948 2.2948 2.2948 2.2948 2.2948 2.2948 2.2948 
0.01 2.3067 2.3089 2.3055 2.2980 2.3052 2.3030 2.2983 2.2981 2.3173 2.2894 
0.02 2.3237 2.3227 2.3178 2.3131 2.3186 2.3164 2.3152 2.3093 2.3259 2.3047 
0.04 2.3578 2.3515 2.3423 2.3433 2.3454 2.3434 2.3495 2.3320 2.3431 2.3357 
0.06 2.3918 2.3802 2.3669 2.3733 2.3721 2.3702 2.3838 2.3548 2.3599 2.3665 
0.08 2.4255 2.4085 2.3912 2.4031 2.3983 2.3969 2.4178 2.3775 2.3769 2.3973 
0.10 2.4590 2.4375 2.4156 2.4329 2.4244 2.4237 2.4519 2.4002 2.3937 2.4282 
Van der Waals Constant (b) (cm3.mol-1) 
0.00 77.6195 77.6195 77.6195 77.6195 77.6195 77.6195 77.6195 77.6195 77.6195 77.6195 
0.01 77.9063 77.8981 77.5127 77.5380 77.5364 77.7905 77.3013 77.2707 77.9126 76.9376 
0.02 78.4491 78.3957 77.9531 78.0180 78.0155 78.2305 77.8996 77.6586 78.2241 77.4191 
0.04 79.5319 79.3879 78.8321 78.9714 78.9688 79.1062 79.0942 78.4349 78.8439 78.3804 
0.06 80.6045 80.3770 79.7089 79.9173 79.9146 79.9827 80.2900 79.2109 79.4608 79.3413 
0.08 81.6696 81.3613 80.5835 80.8557 80.8520 80.8551 81.4852 79.9875 80.0746 80.2981 
0.10 82.7256 82.3417 81.4558 81.7867 81.7830 81.7204 82.6790 80.7621 80.6853 81.2537 
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Table 3.1.4: Some acoustical parameters of MDT series in chloroform at 303.15 K.   
conc. MDT 1 MDT 2 MDT 3 MDT 4 MDT 5 MDT 6 MDT 7 MDT 8 MDT 9 MDT 10 
Specific Acoustical Impedence (Z) (g.cm‐2) 
0.00 1.4183 1.4183 1.4183 1.4183 1.4183 1.4183 1.4183 1.4183 1.4183 1.4183 
0.01 1.4218 1.4240 1.4231 1.4236 1.4231 1.4287 1.4321 1.4210 1.4282 1.4227 
0.02 1.4227 1.4252 1.4247 1.4240 1.4234 1.4298 1.4328 1.4230 1.4297 1.4238 
0.04 1.4256 1.4282 1.4279 1.4259 1.4247 1.4319 1.4341 1.4275 1.4328 1.4273 
0.06 1.4284 1.4312 1.4317 1.4272 1.4259 1.4341 1.4355 1.4319 1.4364 1.4302 
0.08 1.4313 1.4342 1.4349 1.4285 1.4271 1.4362 1.4369 1.4364 1.4395 1.4331 
0.10 1.4342 1.4378 1.4388 1.4305 1.4284 1.4384 1.4388 1.4415 1.4432 1.4366 
Intermolecular free path length (Lf) (A0) 
0.00 0.1793 0.1793 0.1793 0.1793 0.1793 0.1793 0.1793 0.1793 0.1793 0.1793 
0.01 0.1789 0.1786 0.1787 0.1789 0.1787 0.1782 0.1781 0.1791 0.1786 0.1789 
0.02 0.1788 0.1785 0.1785 0.1788 0.1787 0.1781 0.1780 0.1789 0.1785 0.1788 
0.04 0.1784 0.1782 0.1782 0.1786 0.1786 0.1779 0.1779 0.1783 0.1781 0.1785 
0.06 0.1781 0.1779 0.1778 0.1785 0.1785 0.1777 0.1777 0.1778 0.1777 0.1782 
0.08 0.1778 0.1776 0.1774 0.1784 0.1784 0.1775 0.1775 0.1772 0.1774 0.1779 
0.10 0.1775 0.1772 0.1770 0.1782 0.1783 0.1773 0.1773 0.1766 0.1770 0.1775 
Relaxation Strength (r) 
0.00 0.6370 0.6370 0.6370 0.6370 0.6370 0.6370 0.6370 0.6370 0.6370 0.6370 
0.01 0.6352 0.6343 0.6346 0.6361 0.6349 0.6334 0.6343 0.6367 0.6367 0.6364 
0.02 0.6349 0.6340 0.6340 0.6361 0.6349 0.6331 0.6340 0.6358 0.6361 0.6361 
0.04 0.6337 0.6331 0.6328 0.6355 0.6346 0.6325 0.6334 0.6337 0.6349 0.6349 
0.06 0.6325 0.6322 0.6312 0.6352 0.6343 0.6319 0.6328 0.6316 0.6334 0.6340 
0.08 0.6312 0.6312 0.6300 0.6349 0.6340 0.6312 0.6322 0.6294 0.6322 0.6331 
0.10 0.6300 0.6300 0.6285 0.6343 0.6337 0.6306 0.6312 0.6270 0.6306 0.6319 
                
 Contd... 
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Molar compressibility (W.10-3) (cm-1. dyn-1) 
0.00 2.2763 2.2763 2.2763 2.2763 2.2763 2.2763 2.2763 2.2763 2.2763 2.2763 
0.01 2.2834 2.2827 2.2822 2.2771 2.2821 2.2790 2.2725 2.2768 2.2665 2.2769 
0.02 2.2888 2.2868 2.2861 2.2814 2.2865 2.2826 2.2780 2.2805 2.2694 2.2808 
0.04 2.3001 2.2952 2.2939 2.2906 2.2956 2.2899 2.2891 2.2884 2.2750 2.2891 
0.06 2.3115 2.3036 2.3020 2.2996 2.3047 2.2971 2.3002 2.2962 2.2810 2.2972 
0.08 2.3229 2.3120 2.3098 2.3085 2.3138 2.3044 2.3113 2.3040 2.2866 2.3053 
0.10 2.3343 2.3206 2.3178 2.3177 2.3229 2.3116 2.3226 2.3122 2.2925 2.3136 
Van der Waals Constant Molar (b) (cm3.mol-1) 
0.00 81.1395 81.1395 81.1395 81.1395 81.1395 81.1395 81.1395 81.1395 81.1395 81.1395 
0.01 81.3352 81.2794 81.2748 81.1100 81.2730 81.0952 80.8511 81.1300 80.7077 81.1153 
0.02 81.5163 81.4096 81.3905 81.2623 81.4282 81.2098 81.0370 81.2345 80.7866 81.2406 
0.04 81.8774 81.6720 81.6235 81.5659 81.7386 81.4412 81.4109 81.4432 80.9442 81.4910 
0.06 82.2403 81.9312 81.8543 81.8682 82.0485 81.6720 81.7841 81.6528 81.1019 81.7405 
0.08 82.6015 82.1905 82.0861 82.1704 82.3566 81.9026 82.1576 81.8599 81.2577 81.9886 
0.10 82.9621 82.4482 82.3162 82.4725 82.6647 82.1314 82.5298 82.0686 81.4154 82.2363 
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these compounds is shown in Figures 3.1.3 and 3.1.4 for both solvents. In DMF, κs 
values decrease for the compounds MDT-1, MDT-4, MDT-6 and MDT-10 whereas it 
increases for MDT-2, MDT-3, MDT-5, MDT-7, MDT-8 and MDT-9.  In chloroform, for 
all the compounds, κs values decrease as concentration increases. Similar results 
are observed for relaxation strength (r) in both the solvents (as shown in Tables 
3.1.3 and 3.1.4).  
 The decreases of κs and r with increasing concentration might be due to 
aggregation of solvent molecules around solute molecules indicating thereby the 
presence of ion (solute) -solvent interactions. The increase of acoustical impedance 
(Z) (Tables 3.1.3 and 3.1.4) further confirms the solute-solvent interactions in above 
said systems. The reverse nature of κs , r and Z is due to solute-solute interactions 
in the system (as observed in DMF solutions of MDT-2, MDT-3, MDT-5, MDT-7, 
MDT-8 and MDT-9.   
 Further, Rao’s molar sound function (Rm) is observed to increase linearly in 
both the solvents for all the studied compounds as shown in Figures 3.1.5 and 3.1.6. 
The molar compressibility (W) and Vander Waal’s constant (b) are observed to 
increase linearly with concentration for all the compounds in both the solvents 
(0.9990-1.0000). The linear increase shows absence of complex formation in these 
systems. 
 The behaviour of solute in a particular solvent is also studied by the solvation 
number (Sn). Figures 3.1.7 and 3.1.8 show the variation of solvation number with 
concentration in both the solvents. As evident from figures, the solvation number is 
positive for all the compounds and it increases with concentration for all compounds 
except for MDT-8 in chloroform solution. The increase of solvation number is due to 
structure forming tendency whereas reverse is true for structure braking tendency in 
a solution. Thus, the positive and increase of Sn suggests that all the studied 
compounds (except for MDT-8 in chloroform solution) exhibit structure forming 
tendency in the studied solvents. Although increase in compressibility (κs), 
intermolecular free length (Lf), relaxation strength (r) and decrease of velocity (U), 
viscosity (η) in MDT-2, MDT-3, MDT-5, MDT-7, MDT-8 and MDT-9 in DMF suggest 
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existence of solute-solute interactions, increase of solvation number with 
concentration suggest that solute-solvent interactions also exist in these systems. 
The type of interaction depends on the functional groups present in the solute, the 
structure of solute as well as on the solvent molecule. MDT-8 does not contain any 
substitution in aromatic ring due to which, this compound may not be able to interact 
as much as other compounds with chloroform. This results in a decrease of Sn with 
concentration in this system. 
 Thus, in DMF solutions, both solute-solvent and solute-solute interactions 
exist in MDT-2, MDT-3, MDT-5, MDT-7, MDT-8 and MDT-9. However, these 
systems also exhibit structure forming tendency. All other compounds show solute-
solvent interactions and hence structure forming tendency in DMF. In chloroform, all 
the compounds (except for MDT-8) show structure forming tendency whereas 
structure breaking tendency is exhibited by MDT-8. 
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         INTRODUCTION 
 The refractive index is a characteristic property of a substance, which 
depends upon temperature and the wavelength of the light used. It decreases 
with increasing temperature and wavelength. 
 Refractive index is a very useful method to determine the structure and 
identity of unknown compounds. It also determines isotropic and anisotropic 
behaviour of the crystal by the arrangement of atoms (1). From the refractive 
Index values, thermodynamics properties of chemical materials can be computed 
with the help of the measurement of density, molecular mass and specific 
volume. The number of atoms, groups, radicals and bonds present in the 
compound can also be calculated by refractive index measurement. Generally, 
refractive index is a unit less number. Most compounds gives refractive index 
values between 1.3000 and 1.7000, but some materials give negative refractive 
index values and are known as meta materials. These materials were first 
demonstrated for microwave frequencies (2). 
 Refractive index measurements are useful in various industries to control 
manufacturing processes such as fermentation (3), dyes (4), canning (5) and 
preservation of food, determination of purity of polar substances (6) and for the 
identification or assaying of some solids, liquids or constituents of a solution. A 
very well known application is to determine the thickness of film (7-11). Thus, this 
property has been used to study various substances. Dinar et al. have studied 
refractive index of atmospheric aerosol (12). Recently, Wittmann et al. has 
checked the refractive index of semiconductor materials (13). Hubbezoglu et al. 
have concluded that colour changes were found to be stronger in materials with 
larger refractive indices by checking the effect of bleaching of dental composite 
resins on refractive index (14). A very sensitive process of grating of some 
photonic crystal fibre occurs with regular observation in change of refractive 
index (15). An increase of the position of the impurity in a spherical quantum dot 
can be identified by the total refractive index changes (16).  
 Literature survey shows that various researchers have regularly evaluated 
the refractive index of different liquid solutions (17-24).The refractive index of some 
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organic compounds (25, 26), inorganic salts (27, 28), organic-inorganic hybrid 
materials (29), polymeric materials (30-32), optical fibres (33-35), photosensitive 
materials (36), nanomaterials (37, 38), holographic materials (39) membrane protein 
(40) and other materials (41, 42) have also been determined. Solomko and Galadzhii 
have studied refractive index of water-acetone- alcohol systems (43). Refractive 
index of some aliphatic alcohols with dioxane has also been reported by 
Sherstneva and Koleboshin (44). Refractive index of methyl isobutyl ketone + 
pentanols has also been measured by Riggio et al. (45). Aal-Wahaibi et al. 
reported refractive index of ternary system: Isopropyl alcohol + Cyclohexane + 
Water (46). Campos et al. determined the refractive index of Formamide + Water 
system (47).  
 In the present section, the density and refractive index of synthesized 
tetrahydropyrimidine were measured in N, N-dimethylformamide and chloroform 
solutions of different concentrations. Further, molar refraction have been 
evaluated. From these data, the refractive index and density of compounds were 
determined 
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           EXPERIMENTAL 
 The solvents N. N-dimethyformamide and chloroform were of LR grade 
and are fractionally distilled by the reported method 
(51)
. All the studied 
synthesized compounds (MDT 1-10) were recrystalized from chloroform. For 
each compound, a series of solutions of different concentrations were prepared 
in DMF and chloroform solvents.   
  The density and refractive index of solutions were measured by using 
pyknometer and Abbe refractometer respectively. Study of refractive index and 
density was completed at constant temperature viz. 303.15 K, which is 
maintained by circulating water through jacket around the prisms of refractometer 
from an electronically controlled thermostatic water bath (NOVA NV-8550 E). 
The uncertainty of temperature was ±0.1o C. Mettler Toledo AB204-S, 
Switzerland electronic balance with uncertainty of ± 0.0001 g, was used for all 
the weights taken for density measurements. 
 The results are given in Table 3.5.1. 
 
 
 
 
 
 
 
 
  
 
 
 Pa
ge
10
0 
      RESULTS AND DISCUSSION 
 The density of solution (ρ12) is related to densities of the solvent, solute 
and their weight fractions g1 and g2 according to the equation: 
     
1 2
12 1 2
1 g g
ρ ρ ρ= +             … (3.5.1) 
where ρ12 is the density of solution and ρ1 and ρ2 are the densities of solvent and 
solute respectively. Table 3.5.1 shows the experimental values of densities and 
refractive index for all the ten synthesized tetrahydropyrimidine in different 
solutions.  
 The slope of the plot of 1 121 g ρ verses 2 1g g  gives the density of these 
compounds. The plot of 1 121 g ρ  verses 2 1g g  is given in Figure 3.5.1 for MDT-1 
in DMF and chloroform respectively. The densities of all the synthesized 
compounds were evaluated from the slope of such plots. The inverse of slope 
gives density of compound (ρ2). Table 3.5.2 shows these calculated densities for 
all the compounds. Further, the density of compounds were calculated by using 
the following equation (3.5.2), 
     A iKM N Vρ = Δ∑          … (3.5.2) 
ρ indicates the density of the compound, K is packing fraction which is equal to 
0.599, M is for molecular weight of the compound, NA is the Avogadro’s number 
and ∆Vi is the volume increment of the atoms and atomic groups present in the 
compound. The density of all the studied compounds have been evaluated and 
reported in Table 3.5.2. The calculated volume increment ∆Vi for different atomic 
groups are given in Table 3.5.3. 
 Comparison of densities evaluated from graphs and those calculated from 
eq. (3.5.2) showed that calculated values are different from those evaluated 
graphically. For the same compound, density in the two different solvents is 
different. This suggests that one has to consider the role of solvent in the 
measurement of the physical parameters of any solutions. It is because of the  
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Table 3.5.1: The density (ρ12) and refractive index (n) of MDT series in DMF 
at 303.15 K. 
 DMF Chloroform 
Conc.(M) ρ12 (g.cm-3) N 
ρ12 
(g.cm-3) n 
MDT 1  
0.00 0.9416 1.4121 1.4713 1.4397 
0.01 0.9456 1.4231 1.4713 1.4402 
0.02 0.9465 1.4239 1.4715 1.4410 
0.04 0.9483 1.4247 1.4721 1.4421 
0.06 0.9500 1.4255 1.4726 1.4433 
0.08 0.9516 1.4265 1.4731 1.4448 
0.10 0.9535 1.4273 1.4737 1.4458 
MDT 2 
0.01 0.9448 1.4223 1.4717 1.4399 
0.02 0.9452 1.4229 1.4724 1.4404 
0.04 0.9461 1.4238 1.4736 1.4414 
0.06 0.9470 1.4248 1.4749 1.4423 
0.08 0.9479 1.4259 1.4761 1.4433 
0.10 0.9489 1.4268 1.4774 1.4443 
MDT 3 
0.01 0.9486 1.4212 1.4714 1.4400 
0.02 0.9489 1.4228 1.4718 1.4406 
0.04 0.9495 1.4230 1.4727 1.4417 
0.06 0.9501 1.4242 1.4736 1.4428 
0.08 0.9507 1.4252 1.4745 1.4440 
0.10 0.9513 1.4263 1.4754 1.4450 
MDT 4 
0.01 0.9494 1.4219 1.4749 1.4415 
0.02 0.9503 1.4223 1.4753 1.4416 
0.04 0.9520 1.4231 1.4761 1.4420 
0.06 0.9538 1.4239 1.4768 1.4423 
0.08 0.9555 1.4250 1.4776 1.4425 
0.10 0.9573 1.4255 1.4784 1.4428 
MDT 5 
0.01 0.9494 1.4203 1.4720 1.4409 
0.02 0.9503 1.4208 1.4723 1.4410 
0.04 0.9520 1.4217 1.4730 1.4413 
0.06 0.9538 1.4226 1.4736 1.4416 
0.08 0.9556 1.4235 1.4743 1.4418 
0.10 0.9573 1.4244 1.4750 1.4421 
        
         Continue….. 
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.... Continue 
Conc.(M) ρ12 (g.cm-3) n 
ρ12 
(g.cm-3) n 
MDT 6 
0.00 0.9416 1.4121 1.4713 1.4397 
0.01 0.9454 1.4211 1.4747 1.4412 
0.02 0.9458 1.4215 1.4752 1.4414 
0.04 0.9467 1.4222 1.4762 1.4418 
0.06 0.9476 1.4230 1.4772 1.4425 
0.08 0.9484 1.4237 1.4782 1.4426 
0.10 0.9494 1.4244 1.4792 1.4430 
MDT 7 
0.01 0.9529 1.4191 1.4800 1.4408 
0.02 0.9530 1.4200 1.4801 1.4412 
0.04 0.9531 1.4217 1.4803 1.4420 
0.06 0.9532 1.4234 1.4805 1.4426 
0.08 0.9533 1.4252 1.4807 1.4433 
0.10 0.9534 1.4269 1.4809 1.4440 
MDT 8 
0.01 0.9506 1.4225 1.4735 1.4408 
0.02 0.9507 1.4228 1.4737 1.4411 
0.04 0.9508 1.4234 1.4741 1.4416 
0.06 0.9509 1.4239 1.4744 1.4421 
0.08 0.9510 1.4245 1.4748 1.4426 
0.10 0.9511 1.4251 1.4751 1.4431 
MDT 9 
0.01 0.9424 1.4164 1.4809 1.4397 
0.02 0.9429 1.4175 1.4813 1.4400 
0.04 0.9440 1.4195 1.4820 1.4406 
0.06 0.9451 1.4214 1.4827 1.4412 
0.08 0.9462 1.4234 1.4834 1.4418 
0.10 0.9473 1.4253 1.4841 1.4424 
MDT 10 
0.01 0.9562 1.4233 1.4746 1.4396 
0.02 0.9565 1.4238 1.4751 1.4398 
0.04 0.9571 1.4244 1.4763 1.4399 
0.06 0.9576 1.4251 1.4775 1.4401 
0.08 0.9581 1.4257 1.4787 1.4402 
0.10 0.9587 1.4262 1.4798 1.4404 
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Table 3.5.2: Experimental and calculated densities of MDT series in DMF 
and chloroform solutions at 303.15 K. 
Compounds 
Density (g.cm-3) calculated from 
slope of Fig. 3.5.1 in two solvents 
Density (g.cm-3) 
calculated from 
Eqn. 3.5.2 DMF Chloroform 
MDT 1 1.5175 1.6234 1.2960 
MDT 2 1.2270 1.9380 1.2624 
MDT 3 1.2870 1.7825 1.3163 
MDT 4 1.7953 1.8692 1.3565 
MDT 5 1.7699 1.6978 1.3565 
MDT 6 1.2610 2.0121 1.3351 
MDT 7 1.2438 1.8519 1.3664 
MDT 8 1.2315 1.6892 1.2787 
MDT 9 1.2642 2.4213 1.5300 
MDT 10 1.5974 2.0661 1.3877 
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Table 3.5.3: Volume increments of some atoms and groups of atoms. 
Atoms or 
Atomic group 
Volume 
Increments (Ao)3 
Atoms or 
Atomic group 
Volume 
Increments (Ao)3 
C
C
C
N
1 37. 1 4. 10.2 
N
C
C
C 1 37.
1 37.
0.9 
C
C
C
C
. 1 54.1 34 9.0 
 
C N C
1 28.1 37.
 
5.62 
C
C
N
H
1 00. 1 28.
1 48.
 
3.61 
C
O
H
HH
1 091 09. .
1 5.
26.3 
C
C
C
F 11.40 C
C
C
O 11.65 
C Cl
C
C
 
10.39 C Cl
1 77.
 
19.35 
C C N  15.9 O H 4.7 
C F
1 34.
 
9.2 Car O Cal1 37
.1 5. 2.67 
CH
C
C
1 4.
 
14.7 C O H1 37.  5.36 
N
O
O
C 1 21.
1 57.
 
7.46 C N  10.0 
N
N S
C
1.28
1.
48
13.46 
 S C
1.81
 
3.92 
S H
1.354
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facts that, in every solution molecular interactions exist which differ with different 
solvents. This is further confirmed by acoustical parameter which is already 
discussed in Section I. Generally, intermolecular interactions do not affect the 
density but due to the presence of different substituted groups in solutes, 
interactions differ in different solvents which may cause change in volume 
thereby affecting the density of solute in a particular solvent. 
 The molar refraction of a pure liquid (MRD)1 can be calculated by the 
following equation: 
    
( ) 221 11
n MMRD
n ρ
⎡ ⎤−= ⎢ ⎥+⎣ ⎦
             … (3.5.3) 
where n, M and ρ are refractive index , molecular weight and density of pure 
liquid respectively. 
 For solutions, the eq. (3.5.4) was used to determining molar refraction. 
   
( ) 212 1 1 2 2212
12 12
1
1
n X M X MMRD
n ρ
⎡ ⎤ ⎡ ⎤− += ⎢ ⎥ ⎢ ⎥+⎣ ⎦ ⎣ ⎦
                            … (3.5.4)                      
where n12 and ρ12 are refractive index and density of solution respectively. X1 
and X2 are the mole fractions and M1 and M2 are the molecular weight of the 
solvent and solute respectively.   
 The plots of (MRD)12 verses concentration for all the studied compounds 
in DMF and chloroform are given in Figures 3.5.2 and 3.5.3. It is evident from 
these figures that (MRD)12 increases with the increase in concentration. From the 
values of the molar refraction of solution and pure solvent, molar refraction of 
solid compounds were determined by following equation: 
   ( ) ( ) ( )1 212 1 2MRD X MRD X MRD= +                   … (3.5.5)                      
 From the density and molar refraction data, the refractive indexes of all 
the compounds were calculated from eq. (3.5.3). The molar refraction (MRD)2 
and refractive index of all the compounds are reported in Table 3.5.4 for 0.1 M 
solution. 
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 Each solvent interacts differently with different functional groups, so that 
(MRD)2 and refractive index of compounds is different in each solvent, as shown 
in Table 3.5.4. As discussed above, in different solvents intermolecular 
interactions are different, which affect these parameters. In some solvents, 
aggregation or hydrogen bonding takes place whereas in others, breakage of 
bonds takes place. The refractive index and molar refraction depends not only 
upon atomic refraction but also upon single, double or triple bonds. However, it is 
reported that bond refraction is more effective than atomic refraction (52, 53). 
Further, bond polarity also causes change in molar refraction. Thus, type of 
solvent affects the refractive Index and molar refraction of a solute.   
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Table 3.5.4: Calculated molar refraction and refractive index of 0.1 M 
solution of MDT compounds in DMF and chloroform at 303.15 K. 
Compounds 
Solvents 
DMF Chloroform 
(MRD)2 n (MRD)2 n 
MDT 1 121.6168 1.7680 76.5282 1.4703 
MDT 2 127.0079 1.6448 59.2671 1.4469 
MDT 3 114.3017 1.5263 64.0095 1.3921 
MDT 4 99.0076 1.7553 50.4572 1.3539 
MDT 5 94.4151 1.7361 53.7491 1.3576 
MDT 6 109.8296 1.5803 47.0155 1.3722 
MDT 7 119.4055 1.5820 54.0534 1.3677 
MDT 8 104.1181 1.5317 51.6345 1.3419 
MDT 9 112.6901 1.6026 30.0622 1.2799 
MDT 10 96.7712 1.6999 33.7944 1.2784 
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         INTRODUCTION 
 Electrical conductance is a useful method to characterise the properties of 
ionic solution. This property is useful for physico-chemical analysis. The 
conductance of electrolytic solutions depends on the concentration of the ions 
and also on the nature of the ions present. Conductance measurements were 
among the first to be used for determining dissociation constants, solubility 
products and other properties of electrolyte solutions. This technique is also used 
for determining the ionization constant of weak electrolytes, equilibrium 
constants, rates of reactions that proceed with the formation or disappearance of 
ions, and to study of interionic forces. The relative strengths of the two acids or 
bases, solubility of sparingly soluble salts, degree of hydrolysis, basicity of 
organic acids etc. have also been studied by conductometric techniques (1-4). 
Lyashchenko and Lileev relate electric conductivity of aqueous solutions of 
guanidinium salts with rotational mobility of water molecules (5). Reaction rates in 
a radiation-induced chemical reaction can also be studied by means of 
conductivity measurements (6). Dey et al have studied the effect of substituents 
on the solvational behavior of organic compound with the help of conductometric 
and solubility measurements (7). 
 Conductometry is also useful to various biological processes (8-10). It is 
used to determine micro amounts of carbon in aqueous phase (11), ascorbic acid 
in vitamin C tablet (12), carbon in uranium carbide and its solution in nitric acid (13), 
enzymatic degradation of microbial biofilm (14), dye-surfactant ion pair formation 
in aqueous solutions (15) etc. Morita et al reported ionic conductance of polymeric 
electrolytes and of polymeric composite solid electrolytes (16). Arjomandi and 
Holze have characterized polymers on gold electrodes In situ (17). Myllyniemi et 
al. have used an indirect conductometric screening method for the detection of 
antibiotic residues in bovine kidneys (18). Stanisz has used conductometric 
technique to determine electrolyte and osmotic permeability coefficients (19). 
Mehta et al. have used this method to study interactions between diclofenac 
sodium and cyclodextrin molecules in aqueous media (20). Gil et al have studied 
micellization of surfactant system by conductometric method (21).  Literature 
survey shows that conductance of many inorganic and organic compounds have 
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been measured in aqueous (22-27) and non–aqueous solvents (28-31). Jha and 
Saxena have performed conductance study of mixed halocobaltates in 
acetonitrile (32). Mukherjee and Datta have checked the effects of conductance on 
mobility of ions (33). Recently, conductance of some Schiff bases in DMF has 
been measured at different temperatures by Grzeszcuk and Bator (34). Further, in 
our laboratory, some conductance measurements have been done for Schiff 
bases (35, 36). However, not much data was available for heterocyclic ring 
systems. 
    Thus, in present work, conductances of tetrahydropyrimidine derivatives 
in different solutions have measured by using N, N-dimethylformamide and 
chloroform as a solvent at 303.15 K.   
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        EXPERIMENTAL 
All the solvents used were distilled prior to use. The solutions of different 
concentrations were prepared for each compound in DMF and chloroform and 
the conductance of each solution was measured by using Equiptronics 
Conductivity Meter (Model No. EQ-664) having cell constant 0.89 cm-1 at 303.15 
K. The measured conductance was corrected by subtracting the conductance of 
pure solvent. 
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      RESULTS AND DISCUSSION 
 The measured conductance (k) of each solution after correction was used 
to determine the specific conductance (κ), which is then used for the calculation 
of equivalent conductance (λc).  
The equations used for calculating specific conductance (κ) and 
equivalent conductance (λc) are: 
                                   kκ θ=      … (3.3.1) 
                               1000c C
κλ =                … (3.3.2) 
where θ is the cell constant (= 0.89 cm-1) and c is the concentration (g.equi./lit.) 
of solution. 
 These equivalent conductance values of all the tetrahydropyrimidines in 
DMF and chloroform at 303.15 K are reported in Tables 3.3.1 and 3.3.2 along 
with measured conductance (k) except for chloroform solutions of MDT-1 and 
MDT-3, where conductance is almost same as that of pure solvent. Figures 3.3.1 
to 3.3.2 show the variation of conductance with concentration in both the 
solvents. Conductivities of all studied compounds are observed to be less in 
DMF than those in chloroform. Further, for all the systems studied, conductance 
increases with concentration. Figures 3.3.1 and 3.3.2 show that for most of the 
compounds, there is sharp increase in conductance with concentration. 
However, at higher concentration, the values increase very slowly. 
The equivalent conductance (λc) is plotted against √C for all studied 
compounds and is shown in Figures 3.3.3 and 3.3.4. In both DMF and chloroform 
solutions, usually λc increases with dilution In DMF solutions, for most of the 
systems, at lower concentrations, the change in λc values is very less and in 
figures it appears as almost constant whereas at higher concentrations it 
decreases. In chloroform solutions, for most of the compounds much increase or 
decrease is observed at lower concentrations. For MDT-2 and MDT-6, at lower 
concentrations, the change in equivalent conductance is not significant whereas 
for MDT-4, MDT-5 and MDT-7, after 0.10 N, λc decreases and bend downward at  
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Table 3.3.1: The conductance (k) and equivalent conductance (λC) of MDT series in DMF at 303.15 K. 
Conc. 
C 
(g/lit) 
k.105
(Ω)-1
λC 
(cm2/Ω.equiv.) 
k.105
(Ω)-1
λC 
(cm2/Ω.equiv.) 
k.105
(Ω)-1
λC 
(cm2/Ω.equiv.) 
k.105
(Ω)-1
λC 
(cm2/Ω.equiv.) 
k.105
(Ω)-1
λC 
(cm2/Ω.equiv.) 
 MDT 1 MDT 2 MDT 3 MDT 4 MDT 5 
0.000 0.28 --- 0.28 --- 0.28 --- 0.28 --- 0.28 --- 
0.001 0.49 1.8512 0.47 1.7444 0.29 0.0712 0.37 0.8010 0.33 0.4539 
0.002 0.69 1.8512 0.67 1.7444 0.30 0.0757 0.47 0.8455 0.38 0.4539 
0.004 1.12 1.8757 1.06 1.7444 0.34 0.1402 0.68 0.8900 0.49 0.4762 
0.006 1.54 1.8675 1.46 1.7459 0.36 0.1202 0.88 0.8915 0.61 0.4851 
0.008 1.95 1.8634 1.85 1.7455 0.36 0.0857 1.02 0.8244 0.72 0.4884 
0.010 2.36 1.8530 2.24 1.7462 0.36 0.0748 1.18 0.8028 0.79 0.4557 
0.020 2.50 0.9897 2.36 0.9265 0.59 0.1393 1.64 0.6070 1.28 0.4472 
0.040 2.80 0.5614 2.62 0.5211 1.03 0.1675 2.55 0.5049 2.19 0.4243 
0.060 3.08 0.4158 2.84 0.3800 1.41 0.1681 3.35 0.4558 3.12 0.4210 
0.080 3.36 0.3423 3.08 0.3117 1.69 0.1572 4.17 0.4324 3.99 0.4133 
0.100 3.64 0.2992 3.32 0.2707 2.07 0.1595 4.98 0.4185 4.87 0.4087 
 MDT 6 MDT 7 MDT 8 MDT 9 MDT 10 
0.001 0.29 0.0979 0.28 0.0000 0.41 1.1926 0.30 0.1602 0.51 2.0915 
0.002 0.31 0.1424 0.28 0.0044 0.55 1.1926 0.31 0.1602 0.75 2.0915 
0.004 0.34 0.1424 0.28 0.0089 0.81 1.1926 0.35 0.1602 1.22 2.0915 
0.006 0.37 0.1291 0.28 0.0089 1.08 1.1941 0.39 0.1617 1.69 2.0930 
0.008 0.38 0.1101 0.29 0.0089 1.35 1.1937 0.42 0.1613 2.16 2.0926 
0.010 0.39 0.0997 0.29 0.0089 1.62 1.1944 0.46 0.1620 2.63 2.0933 
0.020 0.61 0.1455 0.42 0.0632 1.88 0.7107 0.81 0.2376 3.05 1.2335 
0.040 1.05 0.1709 0.68 0.0894 2.39 0.4690 1.52 0.2755 3.88 0.8014 
0.060 1.40 0.1660 0.95 0.0997 2.90 0.3885 2.22 0.2882 4.71 0.6579 
0.080 1.74 0.1624 1.22 0.1042 3.40 0.3474 2.93 0.2945 5.55 0.5861 
0.100 2.06 0.1586 1.48 0.1070 3.92 0.3241 3.63 0.2983 6.38 0.5431 
 P
a
g
e
1
2
0
 
Table 3.3.2: The conductance (k) and equivalent conductance (λC) of MDT series in chloroform at 303.15 K. 
Conc. 
c 
(g/lit) 
k.107 
(Ω)-1 
λC 
(cm2/Ω.equiv.) 
k.107 
(Ω)-1 
λC 
(cm2/Ω.equiv.) 
k.107 
(Ω)-1 
λC 
(cm2/Ω.equiv.) 
k.107 
(Ω)-1 
λC 
(cm2/Ω.equiv.) 
 MDT 2 MDT 4 MDT 5 MDT 6 
0.000 8.40 --- 8.40 --- 8.40 --- 8.40 --- 
0.001 8.50 8.9000 8.50 8.9000 8.50 8.9000 8.50 8.9000 
0.002 8.60 8.9000 8.50 4.4500 8.50 4.4500 8.60 8.9000 
0.004 8.80 8.9000 8.70 6.6750 8.60 4.4500 8.80 8.9000 
0.006 9.00 8.9000 8.90 7.4167 8.80 5.9333 9.00 8.9000 
0.008 9.20 8.9000 9.10 7.7875 8.90 6.6750 9.20 8.9000 
0.010 9.40 8.9000 9.30 8.0100 9.00 6.2300 9.40 8.9000 
0.020 9.40 4.4500 9.30 4.0050 9.10 3.1150 9.40 4.4500 
0.040 9.50 2.4475 9.30 2.0025 9.10 1.5575 9.40 2.2250 
0.060 9.50 1.6317 9.40 1.4833 9.20 1.1867 9.50 1.6317 
0.080 9.60 1.3350 9.40 1.1125 9.20 0.8900 9.50 1.2238 
0.100 9.60 1.0680 9.50 0.9790 9.30 0.8010 9.50 0.9790 
 MDT 7 MDT 8 MDT 9 MDT 10 
0.001 8.50 8.9000 8.50 8.9000 8.50 8.9000 8.50 8.9000 
0.002 8.60 8.9000 8.60 8.9000 8.60 8.9000 8.60 8.9000 
0.004 8.70 6.6750 8.80 8.9000 8.90 11.1250 8.90 11.1250 
0.006 8.80 5.9333 9.10 10.3833 9.20 11.8667 9.20 11.8667 
0.008 9.00 6.6750 9.30 10.0125 9.50 12.2375 9.40 11.1250 
0.010 9.20 7.1200 9.60 10.6800 9.80 12.4600 9.70 11.5700 
0.020 9.20 3.5600 9.60 5.3400 9.80 6.2300 9.70 5.7850 
0.040 9.30 2.0025 9.80 3.1150 9.90 3.3375 9.80 3.1150 
0.060 9.40 1.4833 9.90 2.2250 9.90 2.2250 9.90 2.2250 
0.080 9.50 1.2238 10.00 1.7800 10.00 1.7800 10.00 1.7800 
0.100 9.70 1.1570 10.20 1.6020 10.10 1.5130 10.10 1.5130 
 Fig
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
d
d
ure 3.3.1:
0
1
2
3
4
5
6
7
0
co
nd
uc
ta
nc
e
10
5 
(m
ho
)
0
1
2
3
4
5
6
7
0
Co
nd
uc
ta
nc
e
10
5 
(m
ho
)
  The var
series in
MDT 1
MDT 6
iation of c
 DMF at 3
0.02
MDT 
0.02
MDT 7
onductan
03.15 K.
 
 
 
0.04
Concent
2 MDT
0.04
Concen
MDT
ce (k) wi
0.06
raction (M
 3 MD
0.06
tration (M)
 8 MD
th concen
0
)
T 4 M
0
T 9 M
tration fo
.08
DT 5
.08
DT 10
r MDT 
0.1
0.1
Pa
ge
11
9 
 Fig
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
d
d
ure 3.3.2:
 
8.0
8.5
9.0
9.5
10.0
10.5
11.0
Co
nd
uc
ta
nc
e
10
7
(m
ho
)
8.0
8.5
9.0
9.5
10.0
10.5
11.0
Co
nd
uc
ta
nc
e
10
7 (
m
ho
)
  The var
series in 
0
MDT 6
0
MDT 1
iation of C
chlorofor
0.02
MDT 7
0.02
MDT 
onducta
m at 303.1
 
 
 
0.04
Conce
MDT
0.04
Conce
2 MDT
nce (k) wi
5 K. 
0.06
ntration (M
 8 MD
0.06
ntration (M
 3 MD
th concen
)
T 9 M
)
T 4 M
tration fo
0.08
DT 10
0.08
DT 5
r MDT 
0.1
0.1
Pa
ge
12
0 
 Fig
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ure 3.3.3:
 
0.0
0.5
1.0
1.5
2.0
2.5
0.
Eq
ui
. C
on
d.
 
(m
ho
.c
m
2 .
eq
ui
‐1
.)
0.
0.
1.
1.
2.
2.
‐0.04
Eq
ui
. C
on
d.
 
(m
ho
.c
m
2 .
eq
ui
‐1
.)
 The varia
series in 
00 0.04
MDT 1
0
5
0
5
0
5
0.00 0.
MDT 6
tion of e
DMF at 30
0.08
MDT 
04 0.08
MDT 7
quivalent 
3.15 K. 
0.12
2 MD
0.12
√C
MDT
conducta
0.16 0.
√C
T 3 M
0.16 0
 8 MD
nce (λC) w
20 0.24
DT 4 M
.20 0.24
T 9 M
ith √C fo
0.28
DT 5
0.28
DT 10
r MDT 
0.32
0.32
Pa
ge
12
1 
 Fig
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
i
d
ure 3.3.4:
 
0
2
4
6
8
10
12
14
0.0
Eq
ui
. C
on
d.
 
(m
ho
.c
m
2 .
eq
ui
‐1
.)
 The varia
series in 
0 0.0
tion of e
chlorofor
5 0.1
MDT 
quivalent 
m at 303.1
 
 
0 0.1
2 MDT
conducta
5 K. 
5 0.2
√C
 4 MD
nce (λC) w
0 0.2
T 5
ith √C fo
5 0.3
r MDT 
0
Pa
ge
12
2 
 Pa
ge
12
3 
low concentrations. For rest of the compounds (MDT-8, MDT-9 and MDT-
10) λc increases after 0.10 N and then decreases. 
This typical behaviour may be due to interactions within the molecule 
thereby causing constriction within the molecule or due to association between 
solute with solvent molecules. Similar behaviour was observed by Singh et al. (37) 
. Haffner et al. (38) have also reported such abnormal behaviour in the studied 
systems and interpreted the results in terms of aggregation or complex formation 
at lower concentration range. This suggests that all the studied compounds 
exhibit weak electrolytic behaviour in DMF and chloroform solutions. So the 
equivalent conductance at infinite dilution for these compounds cannot be 
evaluated. 
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          INTRODUCTION 
 The addition of solute in a solvent causes a change in the heat of solution, 
which is also known as enthalpy change (∆H). If the heat is absorbed i.e., the 
solution is cooler then ∆H is positive. If the heat is evolved i.e., the solution is 
warmer and ∆H is negative. 
 Heat of solution is an important parameter of solubility study, which is a 
key factor for study the behaviour of many species and effect occurs in the 
surrounding medium due to it. Various thermodynamic parameters can also be 
evaluated from heat of solution (1-9). The molar heat of solution and melting 
temperature of a substance can also be determined from the solubility 
measurements at different temperatures (10). The interaction between resin and 
asphaltene micelles can be understood by solubility parameters during 
peptization study of gas oil (11). Gamse et al have studied Organic Flame 
Retardants in Supercritical CO at different temperatures and pressures (12). 
 Computations and observations of solubility parameter is a very useful 
term in pharmaceutical industries. The solubility behavior of drugs remains one 
of the most challenging aspects in formulation development (13). Solubility study 
has been used to determine the ocular doses of different fluoroquinolones (14). 
Simonelli et al have made solubility study to characterize the form of 
sulfathiazole controlling the rate of dissolution when sulfathiazole coprecipitated 
with povidone (15).  
 Solubility proves to be a hopeful study for biologists also. Tanford et al 
have studied the effects of aqueous urea (16, 17) and ethylene glycol solutions (18) 
on protein denaturation on the basis of solubility studies of amino acids and their 
derivatives. It is also reported that solubility play an important role in rapid 
interchange and turnover of bone mineral in the presence of fluctuating serum 
levels of calcium and phosphate (19). Perutz et al have studied the solubility of the 
haemoglobin of sickle-cell anaemia patients (20). Nozaki and Tanford have 
studied the solubility of amino acids, diglycine, and triglycine in aqueous 
guanidine hydrochloride solutions (21). Zager (22) have used the solubility study to 
study the urine pH affects myoglobin (M)-induced renal injury in rats. The 
 Pa
ge
13
0 
presence of a small amount of contaminant in both chymotrypsinogen B and 
chymotrypsin B has also been determined by solubility study (23). The solubility 
studies of some biological compounds have also been reported by GC method 
(24). 
 In our laboratory, study of solubility and evaluation of some 
thermodynamic parameters from solubility data is expanding from some 
synthesized bioactive heterocyclic compounds (25, 26), some biological 
compounds (27) to drug Active Pharmaceutical Ingredients (APIs) molecules (28, 
29). 
 In the present chapter, solubility study of some tetrahydropyrimidine 
derivatives (MDT 1-10) have been done in methanol, ethanol and chloroform at 
various temperatures (293.15 to 313.15 K). 
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EXPERIMENTAL 
 All the synthesized compounds were recrystallized in chloroform. 
Methanol and ethanol are solvents of choice due to its dependence upon 
solubility and relative permeability. All the solvents were purified by fractional 
distillation and its purity was checked by HPLC. 
 The gravimetric method (30) was used to study the solubility. An excess 
mass of compound was added to a known mass of solvent. The solution was 
heated to a constant temperature with continuous stirring. After, at least 3 hr the 
stirring was stopped and the solution was kept at a constant temperature for 2 hr. 
A portion of this solution was filtered and by a preheated injector, 5 ml of this 
clear solution was taken to preweighted measuring vial (m0). The vial was quickly 
and tightly closed and weighted (m1) to determine the mass of the sample (m1- 
m0). To prevent dust contamination, the vial was covered with a piece of filter 
paper. After completely dryness of vial mass, the vial was reweighed (m2) to 
determine the mass of the constant residue solid (m2- m0). All the weights taken 
using Mettler Toledo AB204-S, Switzerland electronic balance with uncertainty of 
± 0.0001 g. The procedure was repeated three times at each temperature. 
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          RESULTS AND DISCUSSION 
 Using the weights of compounds (residues) and solvents, the mole 
fraction (x) of the compound in the solution is determined from equation 1.   
   
2 0 1
2 0 1 1 2 2
( ) /
( ) / ( ) /
m m Mx
m m M m m M
−= − + −                    
... (3.4.1) 
where M1 and M2 are the molar mass of compound and solvent respectively. This 
practical was repeated three times at each temperatures and an average value is 
given in Table 3.4.1. 
 It is obvious from Table 3.4.1 that there is an increase in solubility with 
temperature for all the compounds in the studied solvents. The temperature 
dependence of solubility in solvents is described by the modified Apelblat 
equation (31, 32). 
     ln x = A + B (T/K)                     ...(3.4.2) 
where x is the mass fraction solubility of compound, T is the absolute 
temperature and A and B are the parameters. The results of calculated solubility 
xci are also given in Table 3.4.1. Comparison between the experimental solubility 
and calculated solubility (xci) has been made which gives similar behaviour as 
reported in literature (33, 34). 
 Further absolute average deviations (AAD) and root-mean-square 
deviations (RMSD) were calculated by equations (3) and (4) are listed in Table 
3.4.2. 
               ... (3.4.3) 
    
1/ 22
1
( )
1
N ci i
i
x xRMSD
N=
⎡ ⎤−= ⎢ ⎥−⎣ ⎦∑                                 ... (3.4.4) 
where N is the number of experimental points and xci is the calculated solubility. 
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 In Table 3.4.1 the relative deviations (RD) between the experimental and 
calculated values of solubility are mentioned which was calculated by equation 
(3.4.5). 
            Relative Deviation  cix x
x
−⎛ ⎞= ⎜ ⎟⎝ ⎠             ... (3.4.5) 
 According to van’t Hoff analysis, the standard enthalpy change of solution 
is obtained from the slope the ln x versus 1/T plot. However, in recent 
thermodynamic treatments, some modifications have been introduced in the 
van’t Hoff equation to diminish the propagation of errors and consequently to 
separate the chemical effects from those due to statistical treatment used when 
enthalpy-entropy compensation plots are developed (31). For this reason, the 
mean harmonic temperature (Thm) is used in the van’t Hoff analysis, which is 
calculated by modified van’t Hoff equation.  
 The enthalpy of solution (ΔHsol) was calculated by modified Van’t Hoff 
equation (10). 
    ln
1 1
Sol
hm P
Hx
R
T T
Δ∂ = −⎛ ⎞∂ −⎜ ⎟⎝ ⎠
                   ... (3.4.6) 
where T is the experimental temperature and R is gas constant. Thm is the mean 
harmonic temperature which is given as 
           ( )1hm n
i
nT
T
=
∑
                            ... (3.4.7) 
where n is the number of experimental temperatures. In the present case, the 
Thm value obtained is only 302.99 K. The slope of the plot of ln x versus (1/T-
1/Thm) gives the value of ΔHsol.  
The Gibbs energy change (ΔGsol) for the solubility process was then evaluated 
from intercept of the above plot using following relation (35). 
    ∆Gsol = -RT. intercept             ... (3.4.8) 
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Table 3.4.1: The experimental solubility (x), calculated solubility (xc) and 
relative deviation (RD) of MDT series in methanol at different                     
temperatures. 
Temp. 
K x. 10
3 xc.103 x. 103 xc.103 
 MDT 1 MDT 6 
293.15 5.0027 5.0309 2.9765 2.6330 
298.15 5.0167 5.0460 3.3969 2.9391 
303.15 5.0337 5.0612 3.8218 3.2808 
308.15 5.0474 5.0764 4.2439 3.6622 
313.15 5.0611 5.0916 4.6704 4.0880 
 MDT 2  MDT 7 
293.15 2.1561 1.6945 2.5740 2.5814 
298.15 2.2855 1.7814 2.5826 2.5918 
303.15 2.4118 1.8727 2.5945 2.6022 
308.15 2.5478 1.9687 2.6032 2.6126 
313.15 2.6774 2.0696 2.6152 2.6231 
 MDT 3 MDT 8 
293.15 4.4797 3.6202 2.7468 2.8062 
298.15 4.6153 3.7118 3.0801 3.1012 
303.15 4.7537 3.8057 3.4193 3.4273 
308.15 4.8889 3.9021 3.7579 3.7877 
313.15 5.0237 4.0008 4.0991 4.1860 
 MDT 4 MDT 9 
293.15 1.3729 1.0733 12.722 12.567 
298.15 1.4164 1.1005 12.777 12.617 
303.15 1.4449 1.1283 12.829 12.668 
308.15 1.5000 1.1569 12.884 12.719 
313.15 1.5439 1.1862 12.941 12.770 
 MDT 5 MDT 10 
293.15 3.3490 2.7182 5.5568 4.6902 
298.15 3.3750 2.7318 5.7198 4.8089 
303.15 3.4008 2.7455 5.7340 4.9306 
308.15 3.4614 2.7593 6.0485 5.0554 
313.15 3.4520 2.7731 6.2107 5.1834 
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Table 3.4.2: The experimental solubility (x), calculated solubility (xc) and 
relative deviation (RD) of MDT series in ethanol at different                      
temperatures. 
Temp. 
K x. 10
3 xc.103 x. 103 xc.103 
 MDT 1 MDT 6 
293.15 3.0494 2.9831 2.9892 2.7675 
298.15 3.0648 2.9980 3.1606 2.9123 
303.15 3.0842 3.0130 3.3346 3.0646 
308.15 3.0984 3.0281 3.5005 3.2250 
313.15 3.1167 3.0433 3.6690 3.3937 
 MDT 2 MDT 7 
293.15 1.4552 1.4752 3.3474 2.8199 
298.15 1.6219 1.6222 3.4640 2.9058 
303.15 1.7898 1.7838 3.5815 2.9943 
308.15 1.9589 1.9615 3.6999 3.0854 
313.15 2.1291 2.1570 3.8192 3.1794 
 MDT 3 MDT 8 
293.15 2.6002 2.1726 4.0836 4.0783 
298.15 2.7047 2.2499 4.0900 4.0845 
303.15 2.8096 2.3301 4.0965 4.0906 
308.15 2.9151 2.4130 4.1026 4.0967 
313.15 3.0209 2.4990 4.1306 4.1029 
 MDT 4 MDT 9 
293.15 1.0794 0.9110 2.3117 2.0906 
298.15 1.1596 0.9674 2.3637 2.1329 
303.15 1.2391 1.0272 2.4163 2.1759 
308.15 1.3124 1.0907 2.4694 2.2199 
313.15 1.3907 1.1581 2.5231 2.2647 
 MDT 5 MDT 10 
293.15 5.8600 5.7304 5.8880 4.9087 
298.15 7.3140 6.7921 7.6133 6.0556 
303.15 8.7677 8.0504 9.3768 7.4703 
308.15 10.221 9.5419 11.190 9.2156 
313.15 11.658 11.310 12.858 11.369 
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Table 3.4.3: Coefficient A and B of equation 2, Relative Average Deviation 
(ARD), and root Mean Square Deviation (rmsd) of MDT series in methanol 
and ethanol. 
Compounds A B 108 rmsd 100 ARD 
Methanol 
MDT 1 -5.469 0.0006 0.0209 0.0006 
MDT 2 -9.313 0.01 7.3130 -0.0089 
MDT 3 -7.088 0.005 22.369 -0.0177 
MDT 4 -8.304 0.005 2.6778 -0.0050 
MDT 5 -6.202 0.001 10.975 -0.0117 
MDT 6 -12.39 0.022 6.4896 -0.0090 
MDT 7 -6.195 0.0008 0.0017 0.0001 
MDT 8 -11.74 0.02 0.0623 0.0007 
MDT 9 -4.612 0.0008 0.6629 -0.0037 
MDT 10 -6.829 0.005 21.339 -0.0179 
Ethanol 
MDT 1 -6.109 0.001 0.1213 -0.0012 
MDT 2 -12.09 0.019 0.0062 0.0001 
MDT 3 -8.185 0.007 5.7206 -0.0081 
MDT 4 -10.52 0.012 1.0675 -0.0031 
MDT 5 -15.13 0.034 6.9337 -0.0102 
MDT 6 -8.881 0.0102 1.6770 -0.0045 
MDT 7 -7.631 0.006 8.6080 -0.0104 
MDT 8 -5.591 0.0003 0.0045 -0.0002 
MDT 9 -7.344 0.004 1.4450 -0.0040 
MDT 10 -17.63 0.042 65.689 -0.0340 
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Figure 3.4.1: Plot of ln x vs T/K for MDT-1 methanol. 
 
 
 Using these evaluated ΔHsol and ΔGsol values, the entropies of solutions 
ΔSsol were obtained from equation 
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    solsol
Δ ΔΔ sol
hm
H - GS =
T
          ... (3.4.9) 
All these thermodynamic parameters are given in Table 3.4.4. 
 It is evident from Table 3.4.4 that for all the compounds ΔHsol, ΔGsol and 
ΔSsol values are positive. When stronger bonds are broken and weaker bonds 
are formed, energy is consumed. So, ΔHsol becomes positive (36). This indicates 
endothermic dissolution of compounds where the enthalpy term contributes to an 
unfavourable positive value of ΔGsol. Thus, positive value of ΔGsol indicates that 
the dissolution process is not spontaneous (36, 37). The negative value of entropy 
indicates less randomness in solutions (36). 
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Table 3.4.4: The thermodynamic function of MDT series in methanol and 
ethanol at 302.99 K (Thm). 
Comp. 
code 
∆Hsol 
cal.mol-1 
∆Gsol 
kcal.mol-1
∆Ssol 
cal.mol-1.K-1
∆Hsol 
cal.mol-1
∆Gsol 
kcal.mol-1 
∆Ssol 
cal.mol-1.K-1
 Methanol Ethanol 
MDT-1 0.4470 14.8302 -47.4715 0.8234 14.8302 -46.2293 
MDT-2 8.2716 11.2998 -9.9946 14.5079 11.2998 10.5884 
MDT-3 4.3782 14.9547 -34.9077 5.7225 14.9547 -30.4706 
MDT-4 4.4605 15.1652 -35.3311 9.6276 15.1652 -18.2769 
MDT-5 1.1565 11.7306 -34.8997 26.1558 11.7306 47.6106 
MDT-6 17.1684 11.6039 18.3658 7.8177 11.6039 -12.4963 
MDT-7 0.6058 12.4475 -39.0835 5.0308 12.4475 -24.4787 
MDT-8 15.2645 12.5825 8.8520 0.2333 12.5825 -40.7585 
MDT-9 0.6463 12.8354 -40.2299 3.3762 12.8354 -31.2199 
MDT-10 4.2493 12.4669 -27.1221 32.1004 12.4669 64.8002 
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          INTRODUCTION 
 Thermal analysis has been proved to be a key method in the study and 
characterisation of various materials and finds wide applications in industrial and 
research fields. In thermal analysis, specific physical properties of any material 
are measured as a function of time or temperature. By these measurements, one 
can calculate transition temperature, weight loss, energy of transition, 
dimensional changes, modulus changes viscoelectric properties etc.  
There are various methods of thermal analysis. Some of them are 
differential Scanning Calorimetry (DSC), Differential Thermal Analysis (DTA), 
Thermo Gravimetric Analysis (TGA), Evolved Gas Detection (EGD), Evolved Gas 
Analysis (EGA) etc. 
Interest in thermogravimetry has increased in recent years because of the 
commercial availability of automatic, continuously recording thermo-balances. In 
dynamic thermogravimetry, a sample is subjected to conditions of continuous 
increase in temperature, usually linear with time, whereas in isothermal or static 
thermogravimetry the sample is maintained at a constant temperature for a 
period of time (1). For present study, dynamic thermogravimetry has been 
applied. 
The Differential Scanning Calorimeter records the difference in electric 
power required to keep a test sample and reference material at equal 
temperatures as they are heated or cooled at constant rate. The power 
difference shows up during physical or chemical transitions in the sample and is 
equivalent to the thermal energy absorbed or released during the transition (1). 
Various researchers have regularly studied the thermal behaviour of 
various compounds like rubber (2), reinforced polymer composite (3), monomers 
(4),some nano composites (5),  sugarcane (6), starch blends (7), coal (8),  alumina, 
titania and zirconia membranes (9), semi-conducting composites(10), some 
catalysts (11), crystals(12, 13), alloys(14), drugs (15-18), pharma materials (19-23), dyes(24, 
25), fertilizers (26), inorganic (27-29), organic compounds (30-32) etc. In medical field, 
Thermal analysis of some human body materials have also been studied (33). 
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Blasi et al have compared the devolatilization kinetics of softwood and 
hardwood (34) by TGA. Thermal stability of some Fluorene-Based conjugated 
polymers has been studied by Zena et al (35). Deterioration of historical 
parchments can be studied by various thermal analysis techniques (36). Horowitz 
and Metzgera have given new mathematical interpretation of thermo gravimetric 
traces to determine the kinetic parameters of pyrolysis reactions which is also 
applicable to polymeric systems (37). In our laboratory, thermal studies of various 
bioactive heterocyclic compounds have been done (38).  
In the present section, thermal properties of some tetrahydropyrimidines 
have been studied by TGA and DSC methods. 
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        Theory 
Various kinetic parameters can be calculated from thermo grams of 
particular compound by several methods. All these methods can be applied by 
assuming that thermal and diffusion barriers affects least because small quantity 
of material is used for analysis. The shape of any TGA curve indicates the nature 
of apparatus and the way in which it is used. Arrhenius equation is valid in all 
these methods. .  
  The kinetic computations are generally based on the relationship of the 
type: 
  dC/dt = K f(C)           ... (3.6.1) 
where C represents the degree of conversion, t is time and K is rate constant. 
f(C) is a temperature independent function of C. 
The constant K is assumed to have the Arrhenius form: 
  K = A e -E/RT           ... (3.6.2) 
The degree of concentration C can be given by: 
  C = 1-(W/W0)                     ... (3.6.3) 
where W0 and W are the initial weight of compound at t=0 and weight at any time 
t. Equation (3.6.3) can be written as: 
    (W/W0) = (1-C)           ... (3.6.4) 
W/ W0 is known as residual weight fraction. Thus, the rate of conversion is, 
  dC/dt = - (1/W0) (dW/dt)          ... (3.6.5) 
For homogeneous kinetics, the conversion is assumed to be of the form: 
  f(C) = (1-C)n                 ... (3.6.6) 
where n is the order of the reaction. 
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Substituting the values from equation (3.6.2) and (3.6.6) in equation 
(3.6.1) gives: 
    dC/dt = A e -E/RT (1-C)n 
or   dC/dt = (A/β) e -E/RT (1-C)n             ... (3.6.7) 
where A is the frequency factor, β is the rate of heating and E is the energy of 
activation. 
Various methods for single and multiple heating rates have been reported. 
The methods of single heating rate are as follows: 
1.   Freeman-Carroll 
(38)
 and Anderson-Freeman Method 
(39)
: 
From the thermogram obtained at a single heating rate, the energy of 
activation E and order of reaction n can be evaluated using the following 
Freeman-Carroll equation: 
 ln (dC/dt)/ln (1-C) = n-E/R [(1/T/(∆ln(1-C)]             ... (3.6.8) 
A plot of ln (dC/dt)/ln (1-C) against (1/T)/(∆ln(1-C)) gives a straight line 
with a slope equal to -E/R and the intercept is equal to n.  
Using equation (8), the following equation was derived by Anderson and 
Freeman: 
 (∆ln [dC/dt]) = n (∆ln (1-C)) - E/R ∆(1/T)             ... (3.6.9) 
The plot of (∆ln[dC/dt]) against (∆ln(1-C)) for equal intervals of ∆(1/T) 
gives a straight line with slope equal to n and intercept -E/R∆(1/T). 
2. Sharp-Wentworth method 
(40)
: 
For first order kinetics (n=1), Sharp and Wentworth gave the relation: 
 log [(dC/dt)/(1-C)] = log (A/β) – (E /2.303R).(1/T)      ... (3.6.10) 
The plot of log [(dC/dt)/(1-C)] against 1/T would be a straight line with 
slope equal to - (E/2.303R) and intercept equal to log (A/β). Where β is heating 
rate. 
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3.  Chatterjee Method 
(41)
: 
In this method, order of reaction can be calculated by the equation: 
 n = [log(dW/dt)1-log(dW/dt)2] / (log W1-log W2)          ... (3.6.11) 
where W1 and W2 are the sample weights. This equation was given be 
Chatterjee. 
4.  Horowitz and Metzger method 
(37)
: 
In this method, the value of energy of activation E can be determined from 
a single TG curve by the relation: 
 ln [ln(1-C)-1] = (E/RTs2) θ                                 ... (3.6.12) 
where θ = T-Ts. Ts is the temperature at which the rate of decomposition is 
maximum. The frequency factor A and entropy change ∆S can be determined by 
the following equations: 
 ln E - ln (RTs2) = ln A - lnβ  - E/RTs               ... (3.6.13) 
            A = (kbT / h) e ∆S/R                                    ... (3.6.14) 
where kb is Boltzmann constant and h is Planck’s constant. 
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EXPERIMENTAL 
          Thermo gravimetric analysis (TGA) measurements were made on the 
instrument “Perkin Elmer Thermal Analysis” in nitrogen atmosphere. The heating 
rate was 200C/min for all the synthesized compounds. 
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    RESULTS AND DISCUSSION 
 The TGA thermograms of MDT-1 and MDT-2 are given in Figure 3.6.1. 
From thermograms of all the studied compounds, various thermal properties 
such as initial decomposition temperature, the decomposition temperature range, 
the maximum degradation, the percentage weight loss etc were determined and 
are reported in Table 1. 
 For all the compounds, degradation is single step process. Further, almost 
all the compounds, degration temperature is less than 200 0C. Out of ten 
compounds, MDT-10 is most unstable which is followed by MDT-5. MDT-7 is the 
most stable compound which is followed by MDT-1. All the studied compounds 
have the same central moiety but substitution groups are different. MDT-10 
contains cinnamaldehyde as substitution to aromatic ring. Thus, cinnamaldehyde 
makes the compound unstable whereas chloro group at meta position (as in 
MDT-5) makes it a little bit less stable. However, the presence of nitro group at 
meta position increases the stability as is the case for MDT-7. The variation in 
the trend of thermal decomposition might be interpreted by taking into account 
some intermolecular interactions (structural as well as electronic) and also 
because of several experimental factors. 
 Further, from the thermograms, various kinetic parameters, such as order 
of the degradation (n), energy of activation (E), frequency factor (A) and entropy 
change (∆S) have also been calculated and are reported in Table 3.6.2. It is 
evident that order of reaction is quite different in each studied compound. The 
order of reaction varies from 0.21 to 7.54. The value is minimum for MDt-2 and 
maximum for MDt-4.  
The energy of activation (E) is highest for MDT-5 containing chloro group 
at meta position and minimum for MDT-8 which is without any substitution group. 
The frequency factor (A) is also highest for MDT-5 but minimum for MDT-10. 
Further, change in entropy (∆S0) for all these reactions were also 
calculated by equation (14) and are reported in Tables 3.6.2. The entropy 
change (∆S
0
) is found to be both positive and negative. For MDT-1, MDT-2, 
MDT-4, MDT-5, MDT-6 and MDT-9, the values are positive whereas for others, 
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∆S0 values are negative. The positive value of ∆S0 indicates that the transition 
state is less ordered than the original compound whereas negative value of ∆S
0
 
corresponds to an increase in the order of transition state than the reactants (42). 
Further, DSC of MDT-1 and MDT-2 are shown in Figure 2. From DSC, 
melting points of all the compounds are determined and are given in Table 1 
along with melting points determined by open capillary method. There is good 
agreement between the values evaluated from DSC and those determined by 
open capillary method. 
Thus, the degradation in the studied compounds is single step process 
with different order of reaction.  Further, thermal stability depends upon the type 
of substituent present.  
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Table 3.6.1: TGA data for MDT 1-10. 
Compound 
Code 
 
Amount 
(mg.) 
Initial 
Decomp. 
Temp. 
(°C) 
Decomp. 
Range (°C) 
% Wt.
loss 
Residual 
wt. 
loss (mg.) 
Max. 
Degradation 
Temp. (°C) 
Transition 
DSC 
Temp. 
(°C) 
Open 
capillary 
M.P. 
oC 
MDT 1 5.285 168.52 168.52-310.91 95.55 5.0500 310.91 Endo 138.891 140 
MDT 2 4.614 132.72 132.72-280.91 96.36 4.4461 280.91 Endo 119.320 118 
MDT 3 0.912 159.43 159.43-281.3 94.76 0.8642 281.3 Endo 190.574 190 
MDT 4 6.505 99.87 99.87-200.00 97.24 6.3255 200.00 Endo 167.132 168 
MDT 5 4.009 83.49 83.49-161.27 97.50 3.9088 161.27 Endo 156.850 157 
MDT 6 3.401 125.00 125.00-234.09 99.34 3.3786 234.09 Endo 130.874 130 
MDT 7 2.103 169.64 169.64-287.50 64.55 1.3575 287.50 Endo 98.679 101 
MDT 8 2.734 123.33 123.33-233.33 98.46 2.6919 233.33 Endo 89.816 90 
MDT 9 2.105 96.88 96.88-205.16 99.07 2.0855 205.16 Endo 79.863 81 
MDT 10 2.656 78.19 78.19-418.18 64.48 1.7125 418.18 Endo 162.168 164 
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Table 3.6.2: The kinetic parameters for MDT 1-10 for 1st step. 
Comp. code n 
E 
(kJ) 
A 
(Sec-1) 
∆so 
(J-1) 
MDT 1 2.65 392.5162 8.33×1034 571.16 
MDT 2 0.22 598.6519 3.05×1056 984.42 
MDT 3 2.84 16.03654 9.60×10-01 -97.25 
MDT 4 7.73 620.6761 5.25×1068 1219.97 
MDT 5 0.21 681.7723 1.95×1082 1480.47 
MDT 6 0.27 564.66634 1.76×1058 1018.86 
MDT 7 5.87 28.788971 2.50×1001 -70.24 
MDT 8 2.28 7.7862273 1.09×10-01 -114.55 
MDT 9 1.58 29.586866 1.25×1002 -55.54 
MDT 10 7.54 8.1166256 3.96×10-02 -125.60 
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   INTRODUCTION 
 The acidic or basic strength of material can be highlighted by the 
dissociation constants. They are also known as acidity constant, ionization 
constant or formation constant. The dissociation or ionization constant is 
determined by determining one of the species, at equilibrium. The activity or 
concentration of the other species can be calculated from the amount of the acid 
or base initially introduced and the stoichiometry of the acid base equilibrium.  
 Various methods have been developed for the measurement of 
dissociation constants, such as potentiometry including pH metry (1) 
spectrophotometry (2), conductometry (3), solubility measurements (4), cryoscopy 
(5), measurements of the rates of acid catalyzed hydrolysis of esters (6), 
measurement of the relative distribution of an acid between two immiscible 
solvents (7), dissociation constant by capillary electrophoresis(8), NMR methods(9), 
feedback-based flow ratiometry (10), interfacial fourier transform infrared 
spectroscopy (11) .  
 Spectrophotometry is an ideal method when a substance is not soluble 
enough for potentiometry or when its pKa value is particularly low or high (12-15). 
Various saperation methods are also useful for the determination of dissociation 
constants (16). Bai and Zhang have evaluated the dissociation constants of 
naphthols in β -cyclodextrin by fluorescence method (17). Hansen and Hafliger 
have determined dissociation constant of a weak acid using a dissolution rate 
method (18). Nasser and Mohammad have predicted the acidic dissociation 
constant of some organic compounds using linear and nonlinear QSPR methods 
(19). Al-Alwan et al. have studied the effects of medium on the dissociation 
constants of malic and tartaric acids (20). 
Potentiometry is mostly used for the determination of dissociation 
constants of acids because it is economical in time. Further, it can be used for 
acids of pKa range from 2 to 11 units (21). For this measurement, glass and 
calomel electrodes have been used and carbonate free potassium hydroxide is 
the best alkali to use as a titrant. But, for very low pKa values, this method does 
not give accurate results. In such cases, more sensitive instruments should be 
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used. The activity of the hydrogen ions is measured directly by pH metry. So, 
one can get reliable values of dissociation constant by this method. However, 
there are certain difficulties in mixed aqueous media and nonaqueous media. 
 There are many applications of dissociation constants. The nature of the 
functional groups can be determined by simple comparison of acidity or 
dissociation constant of the unknown compound with those of known 
compounds. The dissociation or formation constant also provide useful 
informations about tautomeric equilibria (22, 23), solvent-solute interactions (24) etc. 
Kinetics study of the dissociation of weak acids and bases is possible by 
polarography and voltammetry technique (25). The distribution coefficients and 
dissociation constants of a series of barbituric acid derivatives have been 
reported by Leyda et al. (26) Funasaki (27) reported the dissociation constants of 
acid-base indicators on the micellar surface of dodecyldimethylamine oxide. 
Levitt (28) studied the determination of the dissociation constant and limiting 
equivalent conductance of a weak electrolyte from conductance measurements 
on the weak electrolyte. Further, in last few years dissociation constant of many 
substances (29-35) have been studied by various workers. 
 In the present work, the dissociation constant of tetrahydropyrimidine 
have studied in dimethyl formamide – water system at 303.15 K. 
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EXPERIMENTAL 
All solutions used for the titration are prepared using distilled water. 
Following are the concentrations of the solutions used for the titration. The 
chemicals used were of B.D.H Analar grade.  
Solutions      Concentration (M) 
Nitric acid      1.0 
Sodium hydroxide      0.5 
Sodium nitrate     1.0 
Ligand (in DMF)                 0.1 
 Nitric acid and sodium hydroxide were standardized by titrating with 0.1 N 
NaOH and 0.05 M succinic acid solution respectively. 
The buffer solutions used for the calibration of pH meter were 0.05 M 
potassium hydrogen phthalate and 0.01 M Borax buffer. 
A Elico pH meter (Model No. Li 610) was used for the pH determination. 
PPC (CL 51) Combined electrode was used as electrode. Before operation, the 
electrode was immersed in 0.1 M HCl for twenty minutes. Then, it was washed 
thoroughly with distilled water. 
Before measurement, the pH meter was calibrated with buffer solution of 
known pH.   
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Calvin Bjerrum pH titration: 
           The following sets of mixtures were prepared for titration: 
(I)   2 ml HNO3 (1.0M) + 4 ml water + 30 ml DMF + 4.0 ml NaNO3 (1.0 M).  
(ii)   2 ml HNO3 (0.1M) + 4 ml water + 28 ml DMF + 2.0 ml ligand solution 
(0.1M) + 4.0 ml NaNO3 (1.0 M).   
  Thus, total volumes (V0) in each set = 40.0 ml and DMF : water ratio  
60:40 (v/v). 
          The above mentioned solutions were allowed to attain a constant 
temperature (303.15 K) and then titrated against standard NaOH solution   (0.5 
M) under an inert atmosphere of nitrogen.  
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     THEORY 
 In the present work ligands are of HL type. Thus, the equilibria are, 
    L H HL+ ↔  
 In general, these equations can be represented as: 
    1j jLH H LH− + ↔  
 The thermodynamic proton-ligand stability constant ( HjTK ) is given by: 
                                       [ ]{ }1 jHj j
LH
TK
LH H−
⎡ ⎤⎣ ⎦= ⎡ ⎤⎣ ⎦
                                    ... (3.7.1) 
TKjH is reciprocal of the thermodynamic dissociation constant of the acid LHj 
dissociating as: 
    1i iLH LH H−= +  
The overall thermodynamic proton-ligand stability constant βjH is given by: 
[ ][ ]
jH
j j
LH
T
L H
β ⎡ ⎤⎣ ⎦=                                                ... (3.7.2) 
and it refers to the reaction: 
    jL JH LH+ ↔  
The stoichiometric proton-ligand stability constant is given by: 
[ ]{ }1 jHj j
LH
K
LH H−
⎡ ⎤⎣ ⎦= ⎡ ⎤⎣ ⎦
                                       ... (3.7.3) 
and 
                                                [ ][ ]
jH
j j
LH
L H
β ⎡ ⎤⎣ ⎦=                                            ... (3.7.4) 
 Pa
ge
16
3 
Pa
ge
16
3 
          An inert electrolyte is used to determine the stability constant in a 
particular salt medium. Sodium nitrate is mostly preferred as supporting 
electrolyte, because of very slight complexing tendency of nitrate ion. Generally, 
the competition between nitrate ion and the ligand under study is minor 
importance. The molar concentrations are used in place of activities. 
         For the determination of dissociation constants, Bjerrum (36) introduced a 
relation for the determination of Hn , which is defined as average number of 
hydrogen bound to each ligand. 
Hn  = {K1H [H] + 2K1H K2H [H]2 + .....JK1H K2H [H] ... KjH [H]j} / {1 + K1H [H] + K1H    
K2H [H]2.....K1HK2H.....KjH [H]j                                              ... (3.7.5) 
From equation (3.7.4), we can write 
                                   
[ ]
[ ]
1
1
jH
j
j
H
jH
j
j
j H
n
H
η
η
β
β
=
=
=
∑
∑
      :  ( )0 1Hβ =                        … (3.7.6) 
Equation (3.7.6) is called Bjerrum formation function of the system. 
         The determination of dissociation or formation constants from experimental 
data comprises the following three steps: (i) evaluation of formation curve of the 
system (ii) calculation of stoichiometric K`s of the system by direct solution of the 
formation function and (iii) conversion of stoichiometric constants into 
thermodynamic constants. 
         When the system consists of a ligand, which is a conjugated base of a 
weak acid, the pH-metric method introduced by Bjerrum has been widely used. 
This method is known as "Bjerrum-Calvin pH titration technique".  
 In this technique, by potentiometer, the concentration of H+ ions is 
measured. Thus, a large amount of data can be obtained in a short period of 
time. The Irving and Rossotti method (37) has some advantages, such as:  
(i) Valid for both pure water and for the mixed solvents.  
(ii) Conversion of pH-meter reading in to stoichiometric hydrogen ion 
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concentration is not necessary. 
(iii) Not necessary to know the stoichiometric concentration of neutral salt 
added to maintain the ionic strength constant.  
Due to these advantages, this method is used in the present work. In this 
method, the pH-meter is standardized using an aqueous buffer. The pH (B) is 
measured for two solutions: (1) A mixture containing a mineral acid, a chelating 
agent and a neutral electrolyte to keep ionic strength constant and (2) A mixture 
same as above but without the chelating agent, when titrated against an alkali 
solution.  
  After each addition of standard alkali, the pH meter reading (B) is noted 
using a glass electrode-saturated calomel electrode combination. For both the 
titrations, same initial volume of the mixture and same standard alkali is used. 
The titration curves obtained in the above two titrations are designated as the 
reagent or ligand titration curve and the acid titration curve respectively.  
          The possible hydrolysis reactions are ignored because (i) fresh reagent 
solutions were used in pH titrations, (ii) titration times were of the order of one 
hour, (iii) there were no observable drifts with time in the meter readings and (iv) 
the concentrations of the mineral acid or alkali in the solutions were small.  
         Usually, a pH-meter calibrated with an aqueous buffer is used for aqueous 
solutions only. However, for the mixed aqueous media, especially aqueous 
dioxane solutions, van Uitert and Haas (38) gave a relation between the glass 
electrode reading B in dioxane-water medium and the stoichiometric hydrogen 
ion concentration of the same in mixture of varied composition and ionic 
strength. They reported the relation: 
                                0log log log HH pH f U
+⎡ ⎤− = + +⎣ ⎦                                  ... (3.7.7) 
where f is the activity coefficient of the hydrogen ions in the solvent mixture 
under consideration at the same temperature and ionic strength, and 0HU  is a  
correction  factor  at  zero ionic strength,  which depends only on the solvent 
composition and temperature. 0HU is taken as unity in aqueous media. The meter 
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reading in any aqueous dioxane solution can, therefore, be converted into 
hydrogen ion concentration using equation (3.7.7), provided that correction factor 
for the appropriate solvent, salt medium, and temperature, has been determined.  
Equation (3.7.7) can be written as: 
                             01 log [ ] Hanti pH H fU
+=                                      ... (3.7.8) 
                               [ ] 0
1
log H
H
anti pH fU
+⎡ ⎤∴ =⎣ ⎦ ⎡ ⎤⎣ ⎦
                              ... (3.7.9) 
Substituting for [H+] in equation (3.7.5) we get, 
Hn  = (K1H/f U0H)[1/antilog B] +....+ ((JK1H K2H...KJH) /(f U0H)J)[1/antilog pH]J 
/(1+K1H/f U0H))[1/antilog B]+..+ ((K1HK2H...KJH)/(f U0H)J)[1/antilogpH]       ...(3.7.10) 
0 .H Hj H jK fU pK=                                         ... (3.7.11) 
0 .H Hj H jfU pβ β=                                              ... (3.7.12) 
         The proton-ligand constant, pKjH can be obtained by the following methods: 
1.   Interpolation at half Hn  values: 
           At the following Hn  values, log K1 and log K2 can be determined: 
 ( )1 0.5log HK n=                                             … (3.7.13) 
                                      ( )2 1.5log HK n=                                              ... (3.7.14) 
2.    Midpoint slope method: 
 For H2L type ligands: 
                                            21 2[ ] 1K K L =  
            or                            1 2 1log 2K K pL=                                   ... (3.7.15) 
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From the measured mid-point slope, D, the ratio K1/K2 can be calculated 
by eq. (3.7.16): 
           
1
2
4.606
2
D
K
K
−= ⎛ ⎞⎛ ⎞+ ⎜ ⎟⎜ ⎟⎝ ⎠⎝ ⎠
                                    ...  (3.7.16) 
          The individual values of K1 and K2 were obtained by using K1/K2 values 
and relation (3.7.15).  
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    RESULTS AND DISCUSSION 
The titration curves obtained in the above two titrations are designated as 
the acid titration curve and ligand or reagent titration curve respectively. The 
titration curves for MDT 1 and MDT 2 are shown in Figure 3.7.1.  
From these curves, the average number of protons associated with ligand 
( Hn ) can be calculated by Irving and Rossotti equation. 
              ( )( ){ } ( ){ }0 0 0 0'' ' 'H Ln Y V V N E V V T= − − + +                     ... (3.7.17) 
where Y is the number of displaceable protons per ligand molecule. V’ and V” are 
the volume of alkali required at the same pH for both acid and ligand titration 
curves respectively. V0 is the initial volume of the test solution. N0, E0 and T0L are 
the initial concentration of the alkali, acid and ligand respectively. For MDT 1 and 
MDT 3, value of Y is 2. Whereas for other compounds, Y is equal to one. 
 The calculated values of Hn  for all the studied compounds are given in 
Table 3.7.1. It is evident from table that Hn  values are in between zero and one 
for all the system except MDT 1 and MDT 3 for which, the values of nH extend 
over the range from 0 to 2 indicating two dissociation steps. The 1
HpK  values at 
Hn = 0.5 were evaluated for each systems except MDT 1 and MDT 3. For these 
two compounds, the 1
HpK and 2
HpK  were calculated at Hn = 0.5 and Hn = 1.5 
respectively. The general plots for the variation of Hn  with B of MDT 1 and MDT 
2 are given in Figure 3.7.2. 
 Further, the ( )log 1H Hn n−  values are plotted against B as shown in 
Figure 3.7.3. The plots are straight lines from which 1log
HpK  values were 
calculated at several B values, by the following equation. 
                                 ( )1log log 1H H HpK pH n n= + −                      … (3.7.18) 
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Table 3.7.1: The pH (B), nH, log pK1H and other terms for MDT series in DMF 
at 303.15 K.  
B V’ V’’ V’’-V’ nH log nH/(1-nH) log pK1H 
MDT 1  
5.40 5.7286 5.8227 0.0941 1.7736 1.0994 6.2941 
5.45 5.7526 5.8947 0.1421 1.6584 0.6430 6.0861 
5.50 5.7765 5.9667 0.1902 1.5430 0.4121 5.9784 
5.55 5.7989 6.0468 0.2479 1.4046 0.2478 5.8727 
5.60 5.8213 6.1269 0.3056 1.2664 0.1398 5.7871 
5.65 5.8426 6.2039 0.3613 1.1331 0.0626 5.7163 
5.70 5.8638 6.2808 0.417 0.9999 -0.0001 5.6499 
5.75 5.8851 6.3577 0.4726 0.8670 -0.0547 5.5838 
5.80 5.9064 6.4346 0.5282 0.7343 -0.1060 5.5136 
11.10 4.4780 5.0700 0.5920 0.5359 -0.1850 10.6272 
11.20 4.4880 5.0867 0.5987 0.5197 -0.1920 10.7262 
11.30 4.4980 5.1029 0.6049 0.5047 -0.1986 10.8251 
11.40 4.5125 5.1190 0.6065 0.5012 -0.2001 10.9243 
11.50 4.5281 5.1352 0.6071 0.5003 -0.2006 11.0232 
11.60 4.5437 5.1513 0.6076 0.4995 -0.2009 11.1223 
11.70 4.5594 5.1674 0.6080 0.4991 -0.2011 11.2218 
11.80 4.575 5.1835 0.6085 0.4984 -0.2014 11.3210 
MDT 2  
4.90 4.4580 4.6406 0.1826 0.5482 -0.5778 4.9840 
5.00 4.4680 4.6563 0.1883 0.5342 -0.5846 5.0595 
5.10 4.4780 4.6719 0.1939 0.5205 -0.5914 5.1356 
5.20 4.4880 4.6875 0.1995 0.5067 -0.5985 5.2117 
5.30 4.4980 4.7030 0.2050 0.4932 -0.6057 5.2882 
5.40 4.5125 4.7212 0.2087 0.4843 -0.6106 5.3726 
5.50 4.5281 4.7435 0.2134 0.4729 -0.6170 5.4528 
MDT 3  
5.40 4.5125 4.2593 -0.2532 1.3743 0.2207 5.7417 
5.50 4.5281 4.2963 -0.2318 1.4274 0.2699 5.8967 
5.60 4.5437 4.3265 -0.2172 1.4636 0.3084 6.0360 
5.70 4.5594 4.3559 -0.2035 1.4976 0.3492 6.1744 
5.80 4.5750 4.3853 -0.1897 1.5319 0.3957 6.3149 
5.90 4.5906 4.4143 -0.1763 1.5651 0.4473 6.4561 
6.00 4.6121 4.4429 -0.1692 1.5828 0.4780 6.5791 
12.05 6.0316 5.5437 -0.4879 0.8341 -0.0676 11.9045 
12.10 6.0842 5.5507 -0.5335 0.7266 -0.1089 11.8563 
12.15 6.1368 5.5577 -0.5791 0.6193 -0.1507 11.8018 
12.20 6.1895 5.5648 -0.6247 0.5123 -0.1953 11.7370 
12.25 6.2200 5.5718 -0.6482 0.4573 -0.2202 11.7220 
12.30 6.2450 5.5789 -0.6661 0.4156 -0.2407 11.7188 
12.35 6.2700 5.5859 -0.6841 0.3737 -0.2629 11.7113 
 
          Contd... 
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B V’ V’’ V’’-V’ nH log nH/(1-nH) log pK1H 
MDT 4  
4.70 4.4380 4.5311 0.0931 0.7695 -0.4937 5.2236 
4.80 4.4480 4.5639 0.1159 0.7132 -0.5118 5.1956 
4.90 4.4580 4.5967 0.1387 0.6568 -0.5319 5.1819 
5.00 4.4680 4.6474 0.1794 0.5562 -0.5741 5.0981 
5.10 4.4780 4.7000 0.222 0.4510 -0.6299 5.0145 
5.20 4.4880 4.7526 0.2646 0.3458 -0.7050 4.9230 
5.30 4.4980 4.8071 0.3091 0.2359 -0.8209 4.7896 
MDT 5  
5.00 4.4680 5.0034 0.5354 0.6756 -0.5250 5.3186 
5.10 4.4780 5.0379 0.5599 0.6153 -0.5483 5.3040 
5.20 4.4880 5.0724 0.5844 0.5550 -0.5746 5.2960 
5.30 4.4980 5.1069 0.6089 0.4948 -0.6049 5.2909 
5.40 4.5125 5.1414 0.6289 0.4459 -0.6331 5.3056 
5.50 4.5281 5.1759 0.6478 0.3997 -0.6634 5.3234 
5.60 4.5437 5.2273 0.6836 0.3119 -0.7354 5.2563 
MDT 6  
5.20 4.4880 4.6550 0.1670 0.5871 -0.5602 5.3528 
5.30 4.4980 4.6800 0.1820 0.5501 -0.5769 5.3873 
5.40 4.5125 4.7050 0.1925 0.5243 -0.5895 5.4422 
5.50 4.5281 4.7263 0.1982 0.5104 -0.5966 5.5180 
5.60 4.5437 4.7467 0.2030 0.4987 -0.6028 5.5977 
5.70 4.5594 4.7671 0.2077 0.4873 -0.6090 5.6779 
5.80 4.5750 4.7876 0.2126 0.4754 -0.6156 5.7572 
MDT 7  
5.80 4.3817 4.4963 0.1146 0.7160 -0.5109 6.2015 
5.90 4.3900 4.5333 0.1433 0.6449 -0.5365 6.1591 
6.00 4.3983 4.5704 0.1721 0.5736 -0.5661 6.1288 
6.10 4.4080 4.6039 0.1959 0.5147 -0.5943 6.1256 
6.20 4.4180 4.6235 0.2055 0.4911 -0.6069 6.1845 
6.30 4.4280 4.6431 0.2151 0.4674 -0.6202 6.2433 
6.40 4.4380 4.6627 0.2247 0.4438 -0.6343 6.3019 
MDT 8  
6.10 4.3817 4.4990 0.1173 0.7093 -0.5132 6.4873 
6.20 4.3900 4.5382 0.1482 0.6328 -0.5412 6.4363 
6.30 4.3983 4.5722 0.1739 0.5692 -0.5681 6.4209 
6.40 4.4080 4.6040 0.1960 0.5145 -0.5945 6.4252 
6.50 4.4180 4.6357 0.2177 0.4609 -0.6240 6.4319 
6.60 4.4280 4.6675 0.2395 0.4070 -0.6583 6.4366 
6.70 4.4380 4.6992 0.2612 0.3534 -0.6986 6.4377 
6.80 4.4480 4.7310 0.2830 0.2996 -0.7473 6.4313 
           
          Contd... 
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B V’ V’’ V’’-V’ nH log nH/(1-nH) log pK1H 
MDT 9  
6.10 4.3817 4.5147 0.133 0.6704 -0.5269 6.4083 
6.20 4.3900 4.5486 0.1586 0.6070 -0.5517 6.3888 
6.30 4.3983 4.5825 0.1842 0.5436 -0.5800 6.3760 
6.40 4.4080 4.6164 0.2084 0.4838 -0.6109 6.3718 
6.50 4.4180 4.6494 0.2314 0.4269 -0.6450 6.3722 
6.60 4.4280 4.6816 0.2536 0.3721 -0.6838 6.3728 
6.70 4.4380 4.7139 0.2759 0.3170 -0.7305 6.3667 
MDT 10  
6.00 4.3733 4.5067 0.1334 0.6693 -0.5273 6.3062 
6.10 4.3817 4.5400 0.1583 0.6077 -0.5514 6.2900 
6.20 4.3900 4.5733 0.1833 0.5458 -0.5790 6.2797 
6.30 4.3983 4.6067 0.2084 0.4837 -0.6109 6.2716 
6.40 4.4080 4.6400 0.2320 0.4253 -0.6461 6.2693 
6.50 4.4180 4.6733 0.2553 0.3678 -0.6871 6.2647 
6.60 4.4280 4.7048 0.2768 0.3147 -0.7327 6.2619 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig
303
 
ure 3.7.2
.15K.  
: The plo
 
t of nH against B for MDT 1 and MDT 2 in DMF at 
Pa
ge
17
2 
Pa
ge
17
2 
 
 
 Pa
ge
17
3 
Pa
ge
17
3 
 The average pK1H value is also reported in Table 3.7.1 for all compounds. 
It is evident from tables that these pK1H values are in agreement with that 
obtained by half-integral method i. e., at Hn = 0.5.  
 For MDT 1 and MDT 3, the proton-ligand constants were calculated by 
solving equation 3.7.1. For all the points below Hn =1, the following equation was 
used 
                                ( )H H H1log pK = pH +log n n -1                           … (3.7.19) 
whereas for the points above Hn =1, the equation used was: 
                                  ( ) ( )Hlogp K = pH +log n -1 2 - n2 ⎡ ⎤⎣ ⎦H H                 … (3.7.20) 
 From the various values of H1log pK  (or log pK2
H), the average value was 
calculated. The values of log pK1H and log pK2H calculated by the two methods 
i.e., half-integral method and average method are given in Table 3.7.2. It is 
observed that in most of the systems, the values are in good agreement.  
However, deviations are observed for MDT 1 and MDT 3. 
 Out of all systems studied, MDT 1 and MDT 3 are of H2L type whereas 
others are of HL type. So, a variation in the single titration curve occurs in MDT 1 
and MDT 3 is observed which is due to ionisation of more than one acidic group 
on a molecule (39). MDT 1 and MDT 3 both contain hydroxyl groups at para 
positions. But, MDT 1 is found to be more acidic than MDT 3. This suggests that 
presence of methoxy group increases the acidic character. This is in agreement 
with the results obtained for quinoline azodyes and their metal complexes (40). 
Yoda has reported that alteration of hydroxy group with any other functional 
group can also change the dissociation of rate of the compounds (41).   
Comparison of 1
HpK  values of MDT series shows that, MDT 5 is more 
acidic which contains m-chloro group. However, MDT 8 and MDT 9 are most 
basic. MDT 8 contains phenyl ring without substitution, whereas in MDT 9, furan 
substitution is present. From these results, it is concluded that different 
compounds exhibit different dissociation constant which also depends upon the 
type and position of substituent group (42). This is due to inductive or mesomeric 
effect of functional groups.  
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Table 3.7.2: The log pK1H values for all the studied compounds calculated 
by different methods. 
Compounds 
log pK1H 
 
log pK1H 
Half-integral 
method 
Average 
method 
Half-integral 
method 
Average 
method 
MDT 1 
5.50 (nH=1.5) 
11.50 (nH=0.5) 
5.83 (nH=1.5) 
11.02 (nH=0.5)
MDT 6 5.50 5.53 
MDT 2 5.20 5.22 MDT 7 6.20 6.20 
MDT 3 
5.70 (nH=1.5) 
12.20 (nH=0.5) 
5.80 (nH=1.5) 
11.78 (nH=0.5)
MDT 8 6.40 6.44 
MDT 4 5.30 5.26 MDT 9 6.40 6.38 
MDT 5 5.00 5.01 MDT 10 6.30 6.28 
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        INTRODUCTION 
 The partition coefficient is a measure of the tendency of the substance to 
prefer a non-aqueous medium rather than aqueous medium. Partition coefficient 
term may also be narrated as distribution coefficient. Partition coefficient, unlike 
solubility, measures the differential ability of a solute to dissolve in two insoluble 
phases.  The value of partition coefficient is a measure of hydrophobicity and 
hydrophilicity of the solute. Normally, one of the solvents chosen is water while 
the second is hydrophobic (1). Other hydrophobic organic solvents like 
chloroform, ether, and hexane can also be used. But n-octanol is an important 
molecule both for biological and environmental reasons (1). Collander has studied 
the partition coefficient of organic compounds in alcohols higher than octanol (2). 
n-octanol is an amphiphilic liquid at room temperature, in which one end is 
hydrophilic and the other is hydrophobic. Due to this property, it is 
pharmaceutically useful. It is a model of phospholipid membranes (3, 4). The 
octanol - water partition coefficient is also used to determine bioavailability and 
environmental fate. Finizio et al.  have used octanol-air partition coefficient as a 
predictor of partitioning of semi-volatile organic chemicals to aerosols like 
pollutants (5). Miller et al. have correlated the octanol-water partition coefficient 
and aqueous solubility (6). 
 Many other industries take into account the partition coefficient or 
distribution coefficients for a number of applications such as in the formulation of 
make-up, topical ointments, dyes, hair colours and many other consumer 
products. In metallurgy,  the partition coefficient is an important factor in 
determining how different impurities are distributed between molten and solidified 
metal (7). Partition coefficient of rare earth elements collected from the terrestrial 
basalt and lunar basalt has been studied (8).  
 Partition coefficients are used extensively in medicinal chemistry, drug 
design, ecotoxicology and environmental chemistry. Governmental and 
international agencies like U.S. Environmental Protection Agency, OECD 
(Organization for Economic Cooperation and Development) recognized the 
partition coefficient method as a physical property of organic pollutants (9-11). This 
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property is also useful in crop science research (12). Partition coefficients of 221 
pesticides and pesticide metabolites have been measured (13).  
 Partition coefficient plays an important role in the pharmaceutical 
research. It is a key tool to draw the transport map of drug in living body. The 
distribution coefficient has a strong influence on ADME properties (Absorption, 
Distribution, Metabolism, and Excretion) of the drug. The hydrophobicity of a 
compound (as measured by its distribution coefficient) plays a major role in 
determining where drugs are distributed within the body after adsorption. Further, 
their metabolism and excretion process can also be studied. For drug, the ideal 
distribution coefficient is usually intermediate (neither too hydrophobic nor too 
hydrophilic) (14-16).  
 Partition coefficient is also useful to determine more useful analogue of 
drug molecule. (17). Ong et al. have studied the partition phenomena to predict 
drug membrane permeability by immobilized artificial membranes (18). Membrane 
permeability of some biological compounds has also been checked by this 
method (19).  
 The traditional method to determine the parttion coefficient is known as 
Shake-Flask method which is a well recognized method (9). There are several 
other methods to measure the partition coefficient like stir flask method (20), vial-
equilibration method (21), reversed-phase HPLC, reversed-phase TLC, slow-
stirring partition methods and column generator method(11), micellar electro 
kinetic capillary chromatography (22), Counter-current chromatography (CCC) (23), 
Microemulsion electrokinetic chromatography (MEEKC) (24) etc. 
 In the present study, partition coefficients of tetra hydropyrimidines have 
been studied in n-octanol-water system by UV spectroscopy at different pH. The 
partition coefficient is highly influenced by pH. So, in the present study, a wide 
range of pH (0.84 to 8.0) is selected. For 0.84 pH, 0.1 N HCl was taken whereas 
for 6.0, 7.4 and 8.0, phosphate buffer was used. These values of pH are selected 
due to their existence in human body. As HCl exists in gastric juice in stomach, 
0.1 N HCl is taken. Blood has 7.4 pH, so the study is done at pH 7.4. Further, the 
middle and upper range of body pH is 6.0 and 8.0 respectively, so study was 
done at these all pH also. 
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     EXPERIMENTAL 
n-Octanol is of analytical grade. The purity of solvent was checked by GC 
and found to be 99.8%. Distilled water was used throughout for all experiments. 
Preparation of standard solution:- 
 10 mg sample was dissolved in n-octanol to give 100 ml solution of 100 
ppm. This solution was known as standard solution. Suitable dilutions were made 
from this standard solution (2 μg to 20 μg).   
Measurement:-  
 λmax values were measured using UV spectrophotometer (Shimadzu, UV-
1700, Pharmaspec) from this solution. For each compound,  absorbance (OD) 
was measured at respective λmax value and the calibration curve of OD versus 
concentration of compounds was drawn. 
Determination of Partition coefficient:- 
 A known amount of the compound under investigation was dissolved in n-
octanol at a concentration not higher than 20 μg. Equal volumes of this solution 
and water is mixed in oven dried stoppered flask and the mixture was stirred for 
24 hrs. at room temperature. After 24 hrs., the solution was transferred into 60 ml 
of separating funnel and allowed to stand in order to separate the aqueous and 
organic layers. The organic layer will be upper one while lower will be aqueous. 
The organic layer was then analyzed by UV spectrophotometer. Using calibration 
curve, the concentration of compounds in organic layer was then evaluated. 
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     THEORY 
Partition coefficient (P) is defined as the ratio of the compounds in organic 
phase to that present in the aqueous phase. i.e., (25) 
    
org
aq
C
P
C
=
    
… (3.5.1) 
where Corg and Caq are concentration of solute in organic and aqueous phases 
respectively. 
 In the present case, concentrations were determined by UV measurement 
so, equation (3.5.1) written as (26): 
     
E
E E
BP
B A
= −     
… (3.5.2) 
where BE= Absorbance before extraction and AE=Absorbance after extraction. 
From equation (3.5.2) log P were calculated for each set of experiment. 
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          RESULTS AND DISCUSSION 
 The values of log P for the studied compounds at different pH are given in 
Table 3.71 and Figure 3.5.1. The log P value depends upon the hydrophilic and 
hydrophobic character of compounds. log P values have inverse relation with 
hydrophilisity of compounds.  
 Table 3.5.1 shows that compounds with higher log P value is hydrophobic 
whereas those with lower log P values are hydrophilic. 
 Observations suggest that for MDT-5 exhibited maximum hydrophobicity 
in most of the pH. Whereas MDT-1 is highly hydrophilic at all pH. Thus, MDT-1 
will be easily absorbed in blood than MDT-5 which is likely to be accumulated in 
fatty tissues (27, 28). The substitution in compound affects its nature. All the 
compounds have same central moiety with different substituents. Thus, the 
presence of vanillin group (as in MDT-1) increases the hydrophilic character 
whereas 3-chlorobenzene causes an increase in hydrophobicity. 
 Overall, the decreasing order of hydrophobicity of compounds is: MDT-5 > 
MDT-4 > MDT-10 > MDT-6 > MDT- 8 > MDT-2 > MDT-7 > MDT-3 > MDT-1. 
 In 0.1N HCl-octanol system, MDT-10 is slightly more hydrophobic than 
MDT-5 whereas MDT-1 is highly hydrophilic in nature. Thus, in gastric juice also, 
MDT-10 will not be absorbed whereas MDT-1 can be easily absorbed. Thus, at 
lower pH, cinnamaldehyde also causes hydrophobicity in a compound. 
 At 6.0  and 8.0 pH, the trend is same as in water i.e., MDT-5 containing 3- 
chloro benzene is highly hydrophobic and MDT-1 containing vanillin group is 
more hydrophilic. 
 In 7.4 pH range, again MDT-4 and MDT-5 exhibited maximum 
hydrophobic character.  
 Over all study of partition coefficients of tetra hydro pyrimidine derivatives 
shows that MDT-5 is most hydrophobic compounds and MDT-1 is most 
hydrophilic compounds at all studied medium.  Thus, there is no apparent effect 
of pH on the order of partition coefficients of the studied compound having 
different substitutions.  
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Table 3.5.1: log P values for compounds of MDT series. 
 
Compounds 
Code 
Max 
absorption
Wavelength 
(nm) 
log P 
Water 0.1N HCl 6.0 pH 7.4 pH 8.0 pH
MDT 1 381 0.2366 0.1392 0.1844 0.0821 0.0640
MDT 2 349 0.4905 0.5021 0.3094 0.1820 0.2173
MDT 3 361 0.4682 0.6142 0.5706 0.1668 0.2255
MDT 4 320 0.8158 0.6167 1.2361 0.2213 0.4059
MDT 5 205 1.1374 0.8279 1.4175 0.2170 0.4191
MDT 6 312 0.6288 0.4681 0.5639 0.1905 0.4033
MDT 7 261 0.4797 0.2831 0.3294 0.1699 0.2390
MDT 8 309 0.5853 0.7181 0.3447 0.1627 0.2446
MDT 10 203 0.7593 0.8808 0.9817 0.1915 0.3931
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         INTRODUCTION 
 Biological activity spectrum of a compound represents the 
pharmacological effects, physiological and biochemical mechanisms of action, 
specific toxicity which can be revealed in compound’s interaction with biological 
system. Further, it describes the intrinsic properties of the compound which 
depends on its structure. 
 Pyrimidines are always an attraction point for researchers because of its 
efficiency towards various pharmacological usages. Pyrimidine nucleosides are 
known to possess various activities like anti-HIV (1), antiviral (2-6), antitumour (7,  8), 
antibacterial (9) anti-inflammatory (10), adrenoceptor antagonists (11-14) etc.  Many 
researchers have worked on antimicrobial activity of dihydropyrimidine moiety. 
Fathalla and co-workers (15) have reported the antibacterial and anticancer 
activity of pyrimidine derivatives. 3,4dihydropyrimidinone derivatives have 
reported to possess the antimicrobial activity (16). Shinde and Bahekar have 
studied the anti-inflammatory activity of pyrimidine derivatives (17). Patil et al. 
have synthesized various derivatives of reduced pyrimidines and screened for 
various biological activities (18). 
 The quinoline derivatives are also known to have wide spectrum of 
therapeutic activities such as: antiulcer (19, 20), anti-HIV (21), antihypertensive (22),   
antimalarial (23-25), antihistamine (26, 27), diuretic (28, 29), herbicidal (30), anticancer (31, 
32) cardiovascular (33) etc. Smith et al have used tetrahydroquinoline as ligand for 
control of gene expression (34). Lombardo et al have characterised 
tetrahydroquinoline derivatives as transferase inhibitors (35). This moiety is also 
known to show the antioxidant activity (36). 
 So, in the present chapter, antibacterial activities of some synthesized 
compounds have been screened against some Gram positive and Gram 
negative bacteria. Sixteen compounds from tetrahydropyrimidine and 
tetrahedroquinoline derivatives have chosen for evaluation and compared. 
 
 
 
 Pa
ge
18
9 
          EXPERIMENTAL 
 The solvent DMSO was also purified before use by standard method (37). 
All the synthesized compounds were recrystallized prior to use. For all the 
compounds, agar well diffusion method was used. 
Test Microorganisms: 
 The synthesized compounds were tested for its antibacterial activity 
against two Gram positive bacteria Stephylococus epidermidis MTCC2639 and 
Bacillus subtilis MTCC1790 and two Gram negative bacteria Escharichia coli 
MTCC729 and Shigella flexneri MTCC1457.  
  Microorganisms were obtained from National Chemical Laboratory (NCL), 
Pune, India and were maintained at 4°C on nutrient agar slants. 
Preparation of test compounds: 
The solutions were prepared at a concentration of 1 mg/μl for all the compounds. 
Preparation of the plates and microbiological assay: 
 The antibacterial evaluation was done by agar well diffusion method (38, 39) 
using Mueller Hinton Agar No.2 as the nutrient medium. The agar well diffusion 
method was preferred to be used in this study because it was found to be better 
than the disc diffusion method (39). The bacterial strains were activated by 
inoculating a loop full of test strain in 25 ml of N-broth and the same was 
incubated for 24 h in an incubator at 37o C. 0.2 ml of the activated strain was 
inoculated in Mueller Hinton Agar. Mueller Hinton Agar kept at 45oC was then 
poured in the Petri dishes and allowed to solidify. After solidification of the media, 
0.85 cm ditch was made in the plates using a sterile cork borer and these were 
completely filled with the test solution. The plates were incubated for 24 h at 
37oC.  The mean value obtained for the three wells was used to calculate the 
zone of growth inhibition of each sample. The controls were maintained for each 
bacterial strain and each solvent. The inhibition zone formed by these 
compounds against the particular test bacterial strain determined the 
antibacterial activities of these synthesized compounds.  
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      RESULTS AND DISCUSSION 
 Table 1 shows the antibacterial activity of tetrahydropyrimidine derivatives 
(MDT series) against Gram positive and Gram negative bacteria. It is evident 
from Table 1 that MDT2, MDT5 and MDT6 showed activity against S. 
epidermidis whereas other compounds could not affect at all. The activity shown 
by MDT2, MDT 5 and MDT 6 are very less.  Further, MDT 5 and MDT 6 show 
equal inhibition.  
All the compounds of MDT series contain same central moiety but 
different substitution. These substitutions are aryl ring with different functional 
groups. MDT5 contains m-chloro group whereas in MDT6 p-flouro group is 
present. In MDT2, methoxy group is present at para position. Thus, activity is 
affected by these functional groups. 
 However, B. subtilis remained unaffected by all the studied 
tetrahydropyrimidine compounds. Thus, B. subtilis is resistant bacteria for the 
studied compounds where not a single group could affect these Gram positive 
bacteria. 
Both the negative bacteria (E. coli and S. flexneri) could not be affected by 
the studied tetrahydropyrimidine compounds.   
 Table 2 shows the activity of studied tetrahydroquinoline compounds 
(MBH series) against Gram positive and Gram negative bacteria. In this case, 
compounds from MBH 1 to MBH 5 showed activity against S. epidermidis. Other 
three compounds had no effect on this bacterium. Further, activity is maximum 
for MBH 1. This compound contains vanillin as a side chain. MBH 4 containing p-
chloro group showed least activity. Thus, vanillin is most effective group in 
against S. epidermidis.  Against B. subitilis, only MBH 4 showed activity which 
contained p-chloro group. Thus, B. subtilis is resistant bacteria for the studied 
compounds 
 It is concluded that for both MDT and MBH series, p-chloro group is 
effective against S. epidemicis and B. subtilis is resistant bacteria. For both 
series, 7th and 8th compounds had no effect at all.   
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Table 1: Antibacterial activity of compounds of MDT series in DMSO. 
Compounds 
Test Bacterial Strain 
Gram Positive Gram Nagative 
S. epidermidis B. subtilis E. coli S. flexneri 
MDT 1 - - - - 
MDT 2 1 - - - 
MDT 3 - - - - 
MDT 4 - - - - 
MDT 5 2 - - - 
MDT 6 2 - - - 
MDT 7 - - - - 
MDT 8 - - - - 
Table 2: Antibacterial activity of compounds of MBH series in DMSO. 
Compounds 
Test Bacterial Strain 
Gram Positive Gram Nagative 
S. epidermidis B. subtilis E. coli S. flexneri 
MBH 1 5 - - - 
MBH 2 3 - - - 
MBH 3 3 - - - 
MBH 4 2 1 - - 
MBH 5 3 - - - 
MBH 6 - - - - 
MBH 7 - - - - 
MBH 8 - - - - 
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 Comparison of activity in MDT and MBH series is shown in Figure 1. It is 
observed that MBH series is slightly more effective than MDT series against 
Gram positive bacteria. Thus, tetrahydroquinoline nucleus ( in MBH series) is 
more fatal than tetrahydropyrimidine moiety. 
 So, it is concluded that for both the series of compounds, S. epidermidis is 
most susceptible bacteria and both Gram negative bacteria (E. coli and S. 
flexneri) are the most resistant. Overall, MBH series is more effective than the 
MDT series in Gram Positive bacteria. For both series, 7th and 8th compounds 
had no effect at all.   
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     A COMPREHENSIVE SUMMARY OF THE WORK 
 The present work is divided into following chapters: 
Chapter-1 
 This chapter describes the importance of heterocyclic compounds with 
aim and objective of the present work. 
Chapter-2 
 This chapter divided into following parts: 
Part-1: Part-1 of this chapter deals with the synthesis of tetrahydropyrimidine 
derivatives. This part consists of two sections. The first section describes the 
synthesis and characterization of tetrahydropyrimidine derivatives and in the 
second section, synthesis of pyrimidopyrimidines by cyclization of these 
tetrahydropyrimidines have discussed. The synthesized compounds are 
characterized by IR, NMR and mass spectral data. The physical constant data of 
the synthesized compounds are also reported. 
Part-2: In this Part, synthesis and characterization of tetrahydroquinoline 
derivatives and their cyclization to synthesize pyrimidoquinoline are described in 
two different sections along with their physical constant data. The synthesized 
compounds are characterized by IR, NMR and mass spectral data. 
Part-3: 3-{[2-aryl-1H-benzimidazol-1-yl]acetyl}-2H-chromen-2-one are synthesi-  
zed by the condensation of two different heterocyclic compounds, i.e; 
benzimidazole and coumarine. The characterization is done by IR, NMR and 
mass spectral data.  
Chapter-3 
 This chapter deals with the physicochemical properties of synthesized 
tetrahydropyrimidines in different solvents. The different properties are given in 
different sections. 
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Section-1: 
 This section deals with the acoustical properties of tetrahydropyrimidines 
(MDT 3 series) over a wide range of concentrations at 308.15K in DMF and 
CHCl3. For this, density, viscosity and ultrasonic velocity of solutions are 
measured. Various acoustical parameters are evaluated from the experimental 
data to understand different types of interactions occurring in the solutions. It is 
observed that for the studied compounds, in both solvents i.e., DMF and 
chloroform, different compounds showed different behaviour. In DMF, both 
solute-solute and solute-solvent interactions exist in solutions of different 
compounds. In chloroform, most of the compounds exhibited solute-solvent 
interactions. 
Section-2: 
 In this section, the refractive index and densities of compounds have been 
measured in DMF and chloroform solutions of various concentrations at 303.15K. 
From the experimental density of solutions, density of solid compounds was 
evaluated and was compared with those observed theoretically. The values of 
evaluated density are found to be different than those calculated theoretically for 
all the studied systems. This may be due to different interactions in different 
solvents. Further, the molar refraction and refractive index of compounds were 
evaluated, which are also found to be different in each solvent. 
Section-3: 
 This section deals with the conductance of studied compounds in DMF 
and CHCl3 at 303.15K. It is observed that conductivities of studied compounds 
are higher in DMF than the other solvent. Further, these compounds exhibit weak 
electrolytic nature in the studied solvents. 
Section-4: 
 This section describes the solubility of all the studied compounds in 
methanol and ethanol at different temperatures (293.15 -313.15 K). It is observed 
that the solubility of all the compounds increases linearly with temperature in 
both the solvents. The thermodynamic parameters such as Gibb’s energy 
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(∆Gsol), enthalpy (∆Hsol) and entropy (∆Ssol) for the dissolution process in the two 
solvents were also evaluated for all the compounds. It is observed that enthalpy 
and Gibb’s energy are positive for all the compounds whereas entropy values are 
both negative and positive. The positive enthalpy indicates endothermic 
dissolution of compounds whereas positive ∆Gsol suggests that the dissolution 
process is not spontaneous. Further, the negative values of entropy indicate less 
randomness in solutions. 
Section-5: 
 The thermal properties of synthesized tetrahydropyrimidines are described 
in this section. DSC and TGA thermo gram were scanned at the heating rate of 
20°C per minute. It is observed that thermal stability depends on the presence of 
substituents in the compound. MDT 10 having cinnamaldehyde is found to be 
most unstable whereas MDT 7 having nitro group is most stable. Further, the 
melting points determined by DSC and by open capillary methods are found to 
be in good agreement. From thermograms, various kinetic parameters such as 
order of reaction, energy of activation, frequency factor and entropy change were 
also calculated. The order of reaction is quite different for different compounds. 
Further, the entropy is found to be both positive and negative in different 
compounds. The positive values of entropy change indicate that the transition 
state is less ordered than the original compound whereas negative value of 
entropy change corresponds to an increase in the order of transition state than 
the reactants. 
Section-6: 
 In this section, the dissociation constants of tetrahydropyrimidines 
compounds are studied in water-DMF mixtures at 303.15 K. The dissociation or 
acidic constant depends not only on the solvent but also on the type of 
substituent groups present in the compound. Different groups interact differently 
with the solvent, which affect their dissociation.    
Out of all systems studied, MDT 1 and MDT 3 are of H2L type whereas others 
are of HL type. MDT 1 and MDT 3, both contain hydroxyl groups at para 
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positions. But, MDT 1 is found to be more acidic than MDT 3. This suggests that 
presence of methoxy group increases the acidic character.   
Among other compounds of HL type, MDT 5 is more acidic which contains 
m-chloro group. However, MDT 8 and MDT 9 are most basic. MDT 8 contains 
phenyl ring without substitution, whereas in MDT 9, furan substitution is present. 
From these results, it is concluded that compounds having different substitution 
groups exhibit different dissociation constant, which is due to inductive or 
mesomeric effect of functional groups.  
Section-7: 
 This section describes partition coefficient of tetrahydropyrimidines 
compounds, which has been studied in n-octanol-water system by UV 
spectroscopy at different pH. From the study, it is concluded that MDT-5 is most 
hydrophobic compounds and MDT-1 is most hydrophilic compounds at all 
studied medium.  
Chapter-4: 
 The antimicrobial activities of tetrahydropyrimidines (MDT series) and 
tetrahydroquinoline compounds (MBH series) are studied in DMSO in this 
chapter. Different Gram positive and Gram negative bacterial strains are used for 
the study. All the studied Gram negative bacteria remained unaffected by the 
studied compounds. But, the presence of different substituents at different 
positions in phenyl ring affects inhibition towards Gram Positive bacteria. 
Comparison between tetrahydropyrimidine and tetrahydroquinoline nucleus 
shows that the tetrahydriquinoline nucleus is more effective than 
tetrahydropyrimidine nucleus for studied bacterial strains. 
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